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Abstract 
In recent years, three-dimensional (3D) printing has opened up unprecedented 
opportunities in the field of tissue engineering, providing researchers with more precise control 
over the macro- and microstructural characteristics of scaffolds. Through the layer-by-layer 
patterning of material, 3D printing enables the production of increasingly sophisticated scaffolds 
that aim to mimic the complexities of native extracellular matrix so as to instruct resident cells to 
synthesize the envisioned tissue. Motivated by the recognized need for tissue-engineering 
solutions for mandibular condyle regeneration, the objective of this thesis was to develop patient-
specific scaffolds with discrete yet integrated osteo- and chondroinductive regions using two 3D 
printing techniques, direct ink writing (DIW) and fused deposition modeling (FDM). Toward this 
objective, chondroinductive hydrogel ‘ink’ comprised of pentenoate-modified hyaluronic acid 
(PHA) and decellularized cartilage (DCC) microparticles was designed for DIW using a 
customized syringe-based extrusion tool. Notably, DCC microparticles were found to enhance 
the rheological properties of the hydrogel ‘ink’ for 3D printing, and accordingly improved the 
resolution of the 3D-printed hydrogel structures. In addition, PHA/DCC hydrogel was shown to 
simulate chondrogenic differentiation of seeded bone marrow-derived mesenchymal stem cells in 
vitro as evidenced by elevated expression levels of SOX9, a chondrogenic gene, demonstrating 
its potential for cartilage tissue engineering applications. In parallel, osteoinductive 
monofilament feedstock for FDM composed of polycaprolactone and hydroxyapatite 
nanopowder was made in-house. Computed tomography and computer-aided design (CAD) 
modeling techniques were used to create digital models of the bone and cartilage-promoting 
regions of the scaffold, with anatomical geometries and regional interconnected pore structures 
for translation into an early prototype. However, due to several technical constraints, multi-
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material scaffold production was unfeasible. To advance scaffold development, a 3D printing 
system with higher resolution and positioning accuracy, and more advanced extrusion tools 
would be required to improve the co-deposition of hydrogel ink and thermoplastic-based 
filament to successfully produce the osteochondral scaffold design.  
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Chapter 1: Introduction 
The long-term objective of this thesis was to develop patient-specific implants or 
scaffolds composed of osteo- and chondroinductive biomaterials using combined three-
dimensional (3D) printing technologies to replace and regenerate the mandibular condyle. Direct 
ink writing (DIW) and fused deposition modeling (FDM) techniques were employed using an 
open-source 3D printer equipped with customized tool heads to enable the computer-driven 
assembly of hydrogels and thermoplastic-based monofilaments into complex, hybrid structures. 
The scaffold was designed to have well-defined yet integrated tissue-specific regions to promote 
the formation of osteochondral tissue similar to that found in the mandibular condyle. The 
dimensions and contours of each region were informed by medical images, and an internal pore 
structure was introduced using computer-aided design (CAD) techniques to enable endogenous 
cell infiltration and tissue ingrowth.  
However, since biomaterials must meet stringent biological, structural and processing 
requirements for utilization in 3D printing for tissue engineering applications, the development 
of ‘printable’ biomaterials continues to remain a significant challenge.1 Therefore, biocompatible 
and cell-instructive biomaterials were also developed to manufacture viable scaffolds with the 
customized 3D printing system. Acellular hyaluronic acid (HA)-based hydrogel ‘ink’ enriched 
with decellularized cartilage (DCC) microparticles was optimized for printing the cartilage 
region of the scaffold, and novel polycaprolactone and hydroxyapatite composite monofilament 
was fabricated for printing the bone region. Biomaterials were selected based on clinical 
translation and commercialization considerations so as to avoid the need for scaffold pre-culture 
or the incorporation of growth factors to bypass the regulatory challenges associated with the 
approval of combination products by the Food and Drug Administration. 
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Due to the interdependency of technical and biomaterial constraints, the scope of this 
thesis was relegated in large part to chondroinductive hydrogel ink design, optimization and 
characterization, though early prototyping of the osteochondral implant was also performed. To 
this end, the first specific aim was to devise a method to print hydrogel and to evaluate the 
printing capabilities and rheological properties of pre-crosslinked HA-based hydrogels with 
various molecular weights of HA, polymer contents and concentrations of DCC microparticles. 
The second aim was to assess the mechanical properties of 3D-printed HA-based hydrogels as 
well as the in vitro response of bone marrow-derived mesenchymal stem cells cultured on the 
hydrogels. The third specific aim was to design and manufacture 3D-printed osteochondral 
implants from medical computed tomography (CT) data with user-defined pore architectures by 
spatially patterning hydrogel ‘ink’ and thermoplastic-based monofilament to construct 
anatomically-relevant, cell-instructive scaffolds for mandibular condyle regeneration. 
 Chapter 2 proposes a set of clinical indications for engineered temporomandibular joint 
components established by a group of field experts including clinicians, surgeons, and 
researchers. In particular, the potential indications for bioengineered mandibular condyle 
implants, including irreparable trauma, developmental or acquired deformities in skeletally 
immature individuals, hyperplasia and documented metal sensitivities, provided the motivation 
to pursue the development of a tissue engineering-based solution to improve treatment outcomes 
for these patient populations. 
Chapter 3 addresses the first and second aim of designing and characterizing a 
chondroinductive hydrogel for 3D printing. The rheological properties and printability of 
pentenoate-modified HA (PHA) hydrogel ‘ink’ with various concentrations of DCC were 
evaluated. Mechanical testing was performed on 3D-printed and mold-casted PHA/DCC 
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hydrogels to assess the effects of DCC concentration and the method of fabrication on the 
structural integrity of the hydrogel. Furthermore, the chondroinductive potential of crosslinked 
PHA/DCC hydrogels was evaluated in vitro. The results from these studies were vital in 
advancing toward the third aim focused on CAD-driven scaffold production through the co-
deposition of hydrogel by DIW and thermoplastic composite material by FDM. 
Chapter 4 addresses the third aim of designing and manufacturing patient-specific 
osteochondral scaffolds for mandibular condyle regeneration using dual extrusion techniques. 
This chapter describes the scaffold design process from CT image acquisition to the generation 
of a digital model, and outlines the work done to date in pursuit of scaffold production using 
combined DIW and FDM techniques. Additionally, this chapter describes the difficulties and 
challenges encountered in 3D printing with novel biomaterials, and explains the limitations that 
need to be overcome or bypassed in order to realize this objective. 
 Chapter 5 provides concluding remarks and summarizes the findings of this thesis. 
Recommendations for future work are also provided along with a full list of constraints that must 
be overcome to produce hybrid scaffolds by the co-deposition of hydrogel ‘ink’ and 
thermoplastic composite monofilament.   
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Chapter 2: Potential Indications for TMJ Tissue Engineering in TMJ Surgery* 
ABSTRACT 
Purpose: Musculoskeletal tissue engineering has advanced to the stage where it has the 
capability to engineer temporomandibular joint (TMJ) anatomical components. Unfortunately, 
there is a paucity of literature identifying specific indications for the use of TMJ tissue 
engineering solutions. The objective of this paper is to establish an initial set of indications and 
contraindications for the use of engineered tissues for replacement of TMJ anatomical 
components. 
Findings: There was consensus among the authors that the management of patients requiring 
TMJ reconstruction as the result of 1) irreparable condylar trauma, 2) developmental or acquired 
TMJ pathology in skeletally immature patients, 3) hyperplasia, and 4) documented metal 
hypersensitivities may be indications for bioengineered condyle/ramus TMJ components. There 
was consensus that Wilkes Stage III internal derangement may be an indication for utilization of 
a bioengineered TMJ disc, or possibly even a disc-like, bioengineered “fossa liner”. However, 
there was some controversy as to whether TMJ arthritic disease (e.g., osteoarthritis) and 
reconstruction after failed alloplastic devices should be indications. Further research is required 
to determine whether tissue engineered TMJ components could be a viable option for such cases. 
Contraindications for the use of bioengineered TMJ components may include TMJ patients with 
multiple failed surgeries, parafunctional oral habits, chronic TMJ infection, TMJ rheumatoid 
arthritis and ankylosis unless the underlying pathology could be resolved. 
                                                
* Published as Salash, J. R., Hossameldin, R. H., Almarza, A. J., Chou, J. C., McCain, J. P., Mercuri, L. G., Wolford, 
L. M., Detamore, M. S. (2016). Potential Indications for Tissue Engineering in Temporomandibular Joint 
Surgery. Journal of Oral and Maxillofacial Surgery, 74(4), 705-711. 
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Conclusions: Biomedical engineers must appreciate the specific indications that may warrant 
TMJ bioengineered structures, so that they avoid developing technologies in search of problems 
that may not exist for patients and clinicians. Instead, they should first focus on identifying and 
understanding the problems that need resolution, and then tailor technologies to address those 
specific situations. The aforementioned indications and contraindications are designed to serve as 
a guide to the next generation of tissue engineers in their strategic development of technologies 
to address specific clinical issues. 
 
INTRODUCTION 
Temporomandibular joint (TMJ) disorders, characterized by pain and/or reduced 
mandibular function, affect millions of individuals nationwide. To improve mandibular function 
and symptom relief in selected individuals with severe, debilitating, end-stage disorders, TMJ 
reconstruction using autogenous grafts or alloplastic implants is often required. Bioengineered 
tissue replacements with the potential to restore health and functionality to the joint may provide 
an attractive alternative to conventional management options. 
As the field of tissue engineering advances, the potential to replace TMJ anatomical 
components is becoming a reality.2-5 To assist researchers in the development of viable 
technologies, direction from clinicians is required to identify the clinical situations where 
bioengineering management strategies may be advantageous. A series of four TMJ 
Bioengineering Conferences in 2006,4 2009, 2012, and 2014, have succeeded in advancing 
directives to bioengineers from clinicians for the development and use of TMJ tissue engineered 
structures. These conferences in many cases successfully identified objectives and potential 
pitfalls associated with tissue engineering technology. However, to date, there is a paucity of 
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literature identifying the specific patient indications justifying TMJ tissue engineering solutions. 
Just as there are a set of accepted indications and contraindications for alloplastic total TMJ 
replacement,6 the objective of this paper aims to establish an initial set of indications and 
contraindications for the use of engineered tissue for the replacement of TMJ anatomical 
components. 
The purpose of the current paper is not to suggest or propose design strategies or specific 
clinical management options. The indications and contraindications proposed clarify for the first 
time patient populations that may benefit from tissue engineering management strategies. 
Furthermore, this paper will help motivate new and emerging bioengineers and clinicians to 
engage in research to improve TMJ replacement outcomes for patients. 
Where there was consensus among the authors versus where there were differing points 
of view will be noted. These agreements and points of controversy both emphasize the need for 
caution and careful investigation and collaboration with clinicians as the TMJ bioengineering 
community advances the field over the next decade. 
 
INDICATIONS FOR MANDIBULAR CONDYLE AND RAMUS BIOENGINEERING 
Bioengineered implants with the ability to regenerate the mandibular condyle and ramus 
could improve the quality of care for many patients requiring surgical intervention or total 
replacement of the TMJ.7 One hurdle for bioengineering in the TMJ field is the success of 
alloplastic total joint replacement,8 as surgeons may be hesitant to abandon a familiar and 
successful approach in favor of new technology. Nevertheless, implantation of a bioengineered 
mandibular condyle/ramus may hold great promise in the management of patients requiring TMJ 
reconstruction as the result of 1) irreparable condylar trauma, 2) developmental or acquired TMJ 
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In patients with irreparable condylar trauma (severe anatomically disruptive 
intracapsular/extracapsular injuries) where conventional surgical intervention is not possible, 
bioengineered implants may be used to reproduce the anatomical form of injured mandibular 
components. Presently, off-the-shelf, or stock alloplastic TMJ devices are useful in such cases 
requiring immediate surgical intervention. However, bioengineered TMJ implants could also be 
used to correct deformities resulting from the inadequate repair or insufficient management of 
the primary injury (e.g., malunion caused by condylar or subcondylar fracture). Malposition of 
the condylar head is a common complication that occurs secondary to extracapsular fractures; so, 
in these cases, biological reconstruction may be advocated to re-establish proper mandibular 
posterior vertical dimension of occlusion. 
 
Skeletally Immature Patients 
Skeletally immature patients requiring TMJ reconstruction may benefit from 
bioengineered replacements, which potentially have the ability to grow with the patient. Patients 
with developmental disorders, such as hemifacial microsomia and Treacher Collins syndrome, 
may be suitable candidates for bioengineered implants. In addition, these implants may be useful 
in the restoration of occlusal vertical dimension in skeletally immature patients who have 
acquired defects involving the TMJ.  
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Classically, pathologic, developmental, and functional disorders affecting the TMJ in 
skeletally immature patients have been reconstructed with autogenous tissues.9-14 In theory, in 
these patients, autogenous allografts will grow with the patient. However, often this so-called 
growth potential has been reported to be unpredictable or to result in ankylosis. These 
complications can occur either as the result of the allograft and/or fixation failure or because of 
the uncooperative nature of the young patient with physical therapy after reconstruction.15, 16 
Recent studies have even questioned the necessity for using an autogenous graft to 
restore and maintain mandibular growth.17, 18 Long-term reports of mandibular growth in 
children whose TMJs were reconstructed with autogenous costochondral grafts demonstrated 
that excessive growth on the treated side occurred in 54% of the 72 cases examined and growth 
equal to that on the opposite side occurred in only 38% of the cases.19-24 Furthermore, Peltomäki 
et al.,25-27 in an investigation of mandibular growth after costochondral grafts, supported 
previous experiments with regard to the inability of the graft to adapt to the growth velocity of 
the new environment. 
In summary, it is reasonable to consider careful examination of the use of bioengineered 
tissue in in skeletally immature patients. Again, problems with autogenous grafts in skeletally 
immature patients include graft failure, unpredictable growth, ankylosis, and potential for donor-
site morbidity. Furthermore, the orthopedic literature has extensively reported success with 
alloplastic devices in improving the quality of life of such patients with severe anatomical and 
functional joint disorders.9 
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Hyperplasia 
Condylar hyperplasia and hypertrophy are other proposed indications for bioengineered 
condyle implantation in skeletally immature patients. These implants may be used to replace 
areas of excessive or disproportionate cellular growth to halt the disease process and reconstruct 
the functional anatomy of the joint. However, precautions must be taken to ensure that all of the 
diseased tissue is excised and that relapse is avoided. The underlying disease process and cause 
of the inherent imbalance of extracellular matrix synthesis, and degradation in the condyle would 
need to be better understood to ensure clinical success. 
 
Metal Hypersensitivities 
Lastly, total TMJ alloplastic joint replacement candidates exhibiting metal 
hypersensitivities28, 29 may benefit from bioengineered implants. Prior to alloplastic joint 
reconstruction, skin patch testing or the more sensitive lymphocyte transformation testing have 
been recommended.30 These tests can help to identify which implant materials affect atopy in 
hypersensitive individuals. If a material hypersensitivity can be documented, then bioengineered 
implants may be desirable to avoid adverse immune reactions and device failure.  
Focal mandibular condylar defects may also be considered a potential indication;31 
although consensus among the authors for this indication was not reached since these 
abnormalities are not frequently observed in the condyle or ramus. There may be a limited set of 
patients who would benefit from focal defect repair, for example those with osteophytes that 
must be removed,32 although the need is not likely large enough to motivate companies to seek 
FDA approval for use in this application. In contrast, there is a significant need to develop 
bioengineering solutions for focal cartilage defect regeneration in other synovial joints such as 
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the knee,33 where isolated cartilage injuries are highly prevalent. This marked difference 
highlights the importance of understanding the therapeutic needs specific to the TMJ to develop 
treatments with clinical relevance. Though the need for focal defect repair in the mandible may 
be negligible, bioengineered implants or plugs may be viable agents for the treatment of chondral 
lesions in the articular eminence. 
 
INDICATIONS FOR ARTICULAR DISC BIOENGINEERING 
Surgical implantation of bioengineered articular discs is a proposed management option 
for patients with unsalvageable discs caused by injury or disease, as well as for patients with 
Wilkes stage III and IV internal derangements or disc displacements without reduction.34 In 
addition, disc implants may be an effective complement to bioengineered condyles to better 
approximate the functional structures of the TMJ in patients requiring total bioengineered joint 
reconstruction.4  
Bioengineering solutions may also be desirable to manage perforations in the articular 
disc,35-38 although there is controversy surrounding whether perforations occur most commonly 
within the disc itself39 or whether they occur more commonly in the attachment tissues 
surrounding the disc. It must be noted that with perforations there are often other associated 
degenerative changes in the TMJ,40 and in those cases, managing the perforation itself may be 
valuable but insufficient without addressing any pathologic condylar changes. Furthermore, there 
is a question as to whether successfully mending a perforation would directly improve function 
or prevent further progressive degeneration of articulating cartilage and bone. 
In cases where the articular disc alone is in need of repair, bioengineered disc 
implantation may be indicated. Common etiological factors that contribute to disc deterioration 
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are mechanical injury, infection and degenerative joint disease. At present, a discectomy without 
subsequent disc replacement is the accepted procedure for the management of irreparable 
articular discs.41 However, discectomies are controversial and their success is highly debatable.42 
Bioengineered disc replacements may therefore offer a promising alternative to exceed current 
management outcomes.42 However, surgical implantation with attachment of the disc to 
surrounding structures, and the ability of the disc to mechanically support articulation are 
significant concerns that must be addressed by both bioengineers and clinicians. Since the disc 
translates with jaw motion and articulates with both the articular eminence and the superior 
surface of the condyle, reestablishing proper disc position and function may be unrealistic. An 
implant that attaches to and lines the fossa may be an alternative viable solution to bioengineered 
disc replacement. 
Internal derangements are another proposed indication for bioengineered disc 
replacement. However, replacement of the disc alone may only be desirable for Wilkes Stage III 
and IV internal derangements. Internal derangements are a result of mechanical dysfunction and 
signs of underlying TMJ pathology. If the underlying pathology is not diagnosed and corrected 
prior to disc replacement, the bioengineered implant may suffer the same fate as the original 
disc. Therefore, bioengineered fossa liners may be preferred over true bioengineered disc 
implants, as such a liner would provide a smooth surface for condylar movements during 
function, and may prevent degeneration of the condyle due to overload associated with 
progression to Wilkes Stages IV and V despite the underlying pathology. 
Disc replacements in combination with bioengineered mandibular components may be 
implanted as a unit when a total joint replacement is indicated. This implantable unit may obviate 
the need for autogenous reconstruction of the condyle and interpositional temporalis muscle. 
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Composite disc and condyle bioengineered replacements would be advantageous for 
management of adolescent idiopathic condylar resorption and reactive arthritis, degenerative 
conditions in which the disc and condyle degenerate past the point of being salvageable. 
Patients may be candidates for bioengineered disc replacements or focal repair unless 
they have an unresolved underlying pathology such as advanced degenerative joint disease, or 
persistent parafunctional habits.43 Synovitis and chondromalacia may or may not be 
contraindications for bioengineered implants, consensus was not achieved among the authors for 
these two indications. 
 
CONTRAINDICATIONS FOR BIOENGINEERED TMJ TISSUES 
The most common complication of TMJ trauma is ankylosis (bone overgrowth), a 
condition where biological reconstruction may be inadvisable. The surgical management goals 
for TMJ ankylosis include restoring function, reducing pain, and preventing recurrence. 
Bioengineered implants may likely suffer the same fate as autogenous grafts, which often fail 
due to recurrence of the ankylosis. Therefore, alloplastic TMJ replacement, as it is in orthopedics 
in other joints, is the management option of choice for TMJ ankylosis.44  
There was some controversy in discussions amongst authors concerning the use of 
bioengineered tissues in an ankylosis environment. On one hand, autologous costochondral 
grafts have been employed in treating select ankylosis cases with varying degrees of success,45-48 
which may pave the way for bioengineered tissue solutions for carefully selected ankylosis 
patients. However, there is significant skepticism at this time for the use of tissue engineering 
approaches in managing ankylosis given that it may unintentionally facilitate the recurrence of 
the ankylosis by stimulating bone overgrowth. 
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Bioengineered TMJ implants also may not be indicated for patients who have undergone 
multiple failed TMJ surgeries or been exposed to failed alloplastic TMJ devices.44, 49 The 
viability of bioengineered implants relies heavily on both the degree of vascularization within the 
implant and the reactivity of the surrounding environment. In patients who have undergone 
multiple operations,38, 49, 50 the formation of thick scar tissue is unavoidable and can impede 
vascular infiltration, leading to poor implant survival and performance.  
Bioengineered implants may further be contraindicated for use in reactive or 
inflammatory environments such as rheumatoid arthritis,51 where the underlying autoimmune 
disease may destroy the regenerated tissue. An unresolved local infection would also be a 
contraindication to implanting a TMJ bioengineered device.52 
 
DISCUSSION 
Due to continued advances in the field of tissue engineering, the use of bioengineered 
implants to regenerate joints is on the horizon. As the creation of viable tissue replacements 
comes closer to becoming a reality, the TMJ clinical community must clearly identify specific 
indications and contraindications for the use of such components. It is imperative that researchers 
in this field understand the needs of the clinicians who manage TMJ patients. This understanding 
will ensure that the solutions developed are both useful and beneficial to TMJ patients, and have 
long-term safety and efficacy. 
The authors have identified four primary TMJ patient populations potentially suitable for 
bioengineered condylar implants. These include the management of patients requiring TMJ 
reconstruction as the result of 1) irreparable condylar trauma, 2) developmental or acquired TMJ 
pathology in skeletally immature patients, 3) hyperplasia, and 4) documented metal 
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hypersensitivities. The authors felt that the use of bioengineered implants were a lower priority 
in patients with focal condylar defects. However, there may be use for an implant to regenerate 
focal defects located in the articular eminence.  
One of the limiting factors for the use of bioengineered tissue would be the presence of 
innate TMJ pathological conditions, such as degenerative joint disease (osteoarthritis), where the 
use of bioengineered TMJ constructs may be of questionable value. For example, low 
inflammatory osteoarthritis resulting from acute or chronic TMJ trauma may be a good 
indication for reconstruction with bioengineered materials since no underlying local or systemic 
immune response exists. However, disorders such as high inflammatory rheumatoid arthritis may 
limit the effectiveness of biological restorations since systemic immune responses would attack 
the bioengineered implant in the same manner as the native condyle unless the underlying 
disease is managed successfully and systemically. Since bioengineered tissue is susceptible to 
the same mechanisms of disease as the natural TMJ, prior to considering bioengineered implants, 
the etiology and pathology of the disease process present must be understood. Therefore, 
presently, alloplastic TMJ replacement is considered the management option of choice for 
patients with end-stage low and high inflammatory TMJ pathology.  
Complications that could be associated with the use of bioengineered tissue in the 
management of TMJ pathology include all of the complications reported for both autogenous and 
alloplastic TMJ TJR.5, 44, 49, 52 The most common being infection, heterotopic ossification and 
ankylosis, unpredictable growth, and persistent post-implantation pain. However, material 
hypersensitivity could be avoided. 
In the future, if bioengineered implants achieve long-term success, the need for 
autogenous grafts may be eliminated. The use of bioengineered devices would reduce the 
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number of surgical sites, eliminate donor site morbidity, and minimize the severity of the 
procedure and recovery time. 
The authors felt there were conditions that may contraindicate the use of TMJ 
bioengineered devices, such as parafunctional oral habits, chronic local TMJ infection, TMJ 
ankylosis, end-stage diseases such as rheumatoid arthritis, multiply operated patients, and 
patients previously exposed to failed alloplastic devices. 
An engineering strategy may not be useful for TMJ replacement in the multiply operated 
patient because scar tissue forms with each surgery, which may affect angiogenesis in the 
bioengineered device due to limited diffusion. This may account for the clinical observation that 
free autogenous tissue grafts, such as cartilage, costochondral and sternoclavicular grafts often 
fail in cases of multiply operated patients or those with extreme anatomical architectural 
discrepancies resulting from pathology.6 Unless angiogenesis can be induced, bioengineered 
implants may not be able to support cellular activity and may thus be prone to failure unless the 
design specifically takes this challenge into consideration. 
Foreign body reactions to wear debris from previous implants may further influence the 
effectiveness of bioengineered replacements by creating an inflammatory environment 
detrimental to tissue. Henry and Wolford53 reported that reconstruction with autogenous 
materials following Proplast-Teflon implant failure was much less predictable than with total 
alloplastic TMJ reconstruction. Therefore, patients with particulate wear debris may 
contraindicate the use of bioengineered tissue devices. 
The authors felt that a bioengineered TMJ disc may be indicated to replace unsalvageable 
articular discs caused by trauma or disease, manage Wilkes Stage III and IV internal 
derangements, and complement bioengineered condyles in total TMJ replacement cases. Another 
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potential use may be in the repair of disc perforations, although the urgency for filling 
perforations is less clear at this time. The utility of bioengineered discs is a point of debate since 
complete disc removal without disc replacement though controversial has yielded satisfactory 
long-term results (i.e., pain reduction and improved joint mobility).41 Also, surgical placement 
and attachment of the disc to surrounding structures is of the utmost concern.4 Since the disc 
must move with opening and closing of the jaw, the device may be prone to failure if it does not 
possess adequate mechanical integrity to oppose all of the forces associated with ginglymo-
diarthroidial articulation. A fossa liner seems to be a more surgically viable approach and can be 
sutured to the fossa to serve as an interpositional buffer between the eminence and condyle to 
promote joint congruence while improving mandibular function. Nonetheless, true bioengineered 
discs may still prove to be an even better option if basic complications relating to attachment, 
articulation and mechanical integrity can be overcome. 
As bioengineers move forward with the translation of engineered tissues, it will be 
necessary to consider both pre-clinical animal models and clinical trials. Although TMJ tissue 
engineering strategies have not yet reached the stage of clinical trials, some consideration has 
been given to animal models. At the first TMJ Bioengineering Conference in 2006, the pig was 
selected as a preferred animal model for TMJ tissue engineering animal studies,4 and in fact a 
porcine model has been employed in a leading TMJ tissue engineering study.54 However, since 
that time, anecdotal concerns have been raised with respect to the continued growth of the 
porcine skeletal structure, and alternate animal models including goats and sheep have been 
suggested. We consider animal model selection an open question that remains to be resolved, but 
we have further reviewed these issues elsewhere.55, 56 In the context of the current paper, we may 
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even suggest that different animal models may be more well suited to different types of 
indications. 
The proposed indications outlined in this paper are intended to be informative, highlight 
early thoughts on the clinical need for bioengineered TMJ devices, and develop a basis for a 
continued dialogue between investigators in this field and clinicians. Investigators are 
encouraged to address these needs by developing innovative management strategies to improve 
outcomes for patients with TMJ disorders. This paper is designed to be used as a resource to help 
justify the significance of TMJ-related bioengineering research, and to guide the field toward 
yielding clinically useful therapies.  
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Chapter 3: Development of Chondroinductive Printable Hydrogel 
INTRODUCTION 
In recent years, three-dimensional (3D) printing has gained significant traction in the 
field of tissue engineering, enabling researchers to construct complex scaffolds at micrometer-
scale resolutions through the controlled deposition of material in sequential layers.57 The upsurge 
of free, open-source 3D printing hardware and software as well as on-line file sharing has made 
it possible to make substantial improvements to commercial desktop 3D printers to facilitate the 
fabrication of novel scaffolds for tissue-engineering applications.58 Printing tools can also be 
created at low-cost to add printing capabilities, such as syringe-based extrusion to enable the 3D 
assembly of novel viscoelastic inks. For personalized scaffold production, diagnostic imaging 
and computer-aided design (CAD) modeling can be used to create digital models with patient-
specific geometries and custom-designed microarchitectures.59 In this manner, scaffolds can be 
designed and manufactured to better mimic the macro- and microscale features of native tissue, 
which direct cell fate and tissue regeneration.60 However, 3D-printed scaffolds that meet the 
biological, chemical and mechanical requirements of native tissue have not yet been realized.61 
To better recapitulate the complexities of native tissue, 3D-printed hydrogels have been 
under development to enhance tissue regeneration and overcome the limitations of hydrogels 
formed by traditional processing techniques, such as mold-casting.62, 63 Hydrogels, which are 
hydrated, 3D polymer networks, have shown great promise as scaffolds for tissue engineering 
due to their aqueous environment, efficient nutrient flux, tunable mechanical properties, and 
ability to sustain cellular activities and induce tissue-specific differentiation.61, 64, 65 In particular, 
hydrogels based on natural polymers, such as alginate, chitosan, hyaluronic acid and gelatin, 
offer various advantages over synthetic hydrogels and are predominately used in tissue 
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engineering since they contain biochemical and biophysical stimuli that encourage positive cell-
material interactions, which are essential for cell adhesion, proliferation and differentiation.63, 66 
However, the printability and bioactivity of natural hydrogels may vary from batch-to-batch. 
Variations in material properties make scaffold reproduction challenging and material-induced 
cell responses unpredictable.67 In general, natural hydrogels also have limited mechanical 
robustness compared to hydrogels made with synthetic polymers.62 Besides these intrinsic 
disadvantages, it has been widely observed that there is an opposing relationship between the 
printability of a given hydrogel and its efficacy in vitro.67 Optimal printability and shape 
maintenance is often achieved with high molecular-weight polymers, degrees of crosslinking and 
polymer concentrations, whereas cells tend to thrive best when the same properties are 
dramatically lowered.67 This inverse relationship drives researchers to select hydrogel properties 
in the intermediate range to balance cellular activity with shape fidelity. To date, several 
acellular and cell-laden hydrogel inks have been investigated, but there is still a shortage of 
printable yet cell-instructive hydrogels.66 Therefore, advanced hydrogel inks must be developed 
to overcome these opposing requirements. 
Hydrogel printing through syringe-based extrusion operates at ambient conditions and 
dispenses filamentous strands of viscoelastic ink in a layer-by-layer fashion.68 For successful 
printing, hydrogel inks must flow and not obstruct the extrusion tool, and must be rapidly 
stabilized once deposited to maintain the shape and structure of the deposited layer so that 
successive layers can be printed on top without detrimental effects.68 Hydrogel printing 
resolution and cell survival, proliferation and differentiation are reliant on many factors and their 
interactions including: polymer concentration, molecular weight, gelation mechanism, 
mechanical properties, crosslinking density, rheological properties, print head positioning and 
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extrusion accuracies, and printing parameters.67 High-viscosity, shear-thinning inks with 
observable yield stresses are ideal so that the material flows more easily through the dispensing 
tip where it is exposed to high shear stresses, and is prevented from flowing when low or 
negligible shear stresses are applied.67 High viscosities and yield stresses also serve to prevent 
filament collapse once deposited. However, even the most viscous inks will still experience 
flattening and losses in shape fidelity over time. Therefore, it is of great benefit for the printed 
hydrogel ink layers to be quickly stabilized through post-deposition crosslinking to achieve long-
term structural integrity. 
Hyaluronic acid (HA) is a non-sulfated glycosaminoglycan, is an essential component of 
articular cartilage, and can be functionalized to form photocrosslinkable hydrogel ink. 
Furthermore, to improve cartilage regeneration therapies, there is a growing interest in the 
incorporation of extracellular matrix (ECM) derived from articular cartilage into scaffolds to 
better replicate the native cellular environment since the matrix contains cartilage-specific 
growth factors and epitopes. Cartilage ECM-based scaffolds have been shown to promote 
cartilage-specific differentiation in the absence of exogenous growth factors, and several studies 
have also reported enhanced cartilage repair in vivo.69-71 To prevent adverse immune response in 
the host, native tissues must go through a process called decellularization to remove cellular 
components and associated epitopes that elicit foreign body reactions. Our group has previously 
demonstrated that micron-sized decellularized cartilage (DCC) enhanced methacrylated 
hyaluronic acid (MeHA) hydrogel for direct injection into focal cartilage defects to initiate 
hyaline cartilage regeneration.72 From previous studies, MeHA/DCC pre-gel was shown to 
exhibit paste-like rheological properties, and had observable yield stresses that enabled it to be 
injected into cartilage defects without flowing away.72 The pre-gel once applied could be spread 
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into place and photocrosslinked in situ. Furthermore, this material was found to guide 
chondrogenesis.72  
While injectable MeHA/DCC pre-gel is useful for focal defect repair, an injectable 
hydrogel treatment would not be appropriate for the repair of large-sized defects with complex 
structures. 3D-printed hydrogels customized to exact patient specifications would be more 
suitable for large defect repair or joint resurfacing, and would better reproduce the anatomical 
structure of the articular cartilage unique to each patient. Though MeHA/DCC pre-gel possesses 
rheological properties that are favorable for 3D printing, it has a curing time of approximately 15 
minutes, making it impractical for multilayered 3D construction, which demands rapid 
crosslinking. Therefore, different crosslinking chemistry was employed in the current study to 
improve gelation time in order to quickly stabilize printed hydrogel layers and decrease printing 
times. Pentenoate groups were attached to the HA backbone to facilitate photocrosslinking 
through thiol-ene ‘click’ chemistry (Figure 3.1). These ‘click’ reactions are highly efficient and 
reduce the gelation time to 2.8 min, making pentenoate-modified HA (PHA) a more viable 
alternative to MeHA for 3D printing.73 
The objective of the study was therefore to design and optimize hydrogel ink comprised 
of PHA and DCC microparticles for extrusion-based printing, and test the efficacy of the 
crosslinked hydrogels for cartilage regeneration. To establish hydrogel printing capabilities, 
open-source hardware and software were used to build a syringe-based extrusion tool, which was 
connected to an FDM 3D printer. Next, studies were performed to evaluate the printability and 
associated rheological properties of PHA hydrogels with various polymer molecular weights, 
polymer contents and concentrations of DCC microparticles. The mechanical properties and 
swelling behavior of the hydrogels were also evaluated to determine the robustness and 
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equilibrium swelling behavior of the hydrogels. Lastly, the efficacy of PHA/DCC hydrogel for 
articular cartilage regeneration was investigated in vitro by evaluating cellular adhesion, 
proliferation, chondrogenic gene expression, and through microscopic visualization of the 
neotissue using histological staining.  
 
MATERIALS AND METHODS 
Materials Synthesis 
Pentenoate-Modified Hyaluronic Acid 
To synthesize hyaluronic acid capable of photo-polymerization, hyaluronic acid was 
functionalized with pentenoate groups through the esterification of free hydroxyl groups on the 
polymer backbone with pentenoic anhydride as described by Mergy et al.73 (Figure 3.1A). 
Briefly, 1 w/v% sodium hyaluronate (1 MDa, Lifecore Biomedical, MN) was solubilized in 
deionized water and mixed with dimethylformamide (DMF) to achieve a DMF/water v/v ratio of 
2:3. Under continuous stirring, 4-pentenoic anhydride (Sigma-Aldrich, MO) was added in 5-fold 
molar excess to sodium hyaluronate, and the pH of the mixture was maintained between 8 and 9 
through periodic additions of 0.5M NaOH. Once the pH ceased to change (about 6 hours), 
sodium chloride (NaCl) was added to achieve a 0.5M NaCl solution. The product was 
precipitated in acetone, which was added to the reaction mixture to obtain an acetone/water v/v 
ratio of 5:1. The precipitate was collected by centrifugation at 7800 rpm and subsequently 
dissolved in deionized water, loaded into dialysis tubing (3500 Da molecular weight cut-off) and 
dialyzed against deionized water for 48 hours. The purified PHA was then freeze-dried and 
stored at -20°C. The purity and degree of functionalization was determined through 1H NMR 
spectroscopy. 
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Micron-Sized Decellularized Cartilage 
Ten porcine knee joints from male Berkshire hogs were obtained from Bichelmeyer 
Meats (Kansas City, KS) and articular cartilage from the pattelofemoral and tibiofemoral 
surfaces was shaved off with a scalpel. Cartilage shavings were rinsed with deionized water and 
stored at -20°C until further processing. Prior to decellularization, the cartilage shavings were 
fragmented into coarse granules to decrease the diffusion distance required for decellularization 
agents to reach inhabiting cells, and was performed using a high-speed blade mill 
(CryogenicTissueGrinder, Bio Spec Products, Bartlesville, OK) in the presence of dry ice. After 
fragmentation, the coarse-ground cartilage was stored overnight at -20°C to allow for dry ice 
sublimation. To test the efficiency of the decellularization process, a portion of coarse-ground 
cartilage was retained for further analysis (i.e., fluorometric double-stranded (ds) DNA 
quantitation). Decellularization was carried out following the protocol described in Sutherland et 
al.,69 which involves the successive immersion and agitation of coarse-ground cartilage in 
various decellularization agents including: hypertonic solutions, ionic and nonionic detergents, 
enzymatic nuclease solution and ion exchange resin suspensions.  
To summarize, coarse-ground cartilage was packaged into pre-soaked dialysis tubing 
(3500 Da molecular weight cut-off), sealed with clamps and placed in wide-mouth jars 
containing hypertonic saline solution to induce cell shrinkage and detachment from surrounding 
extracellular matrix.74 The jars were placed in a shaking incubator and were maintained at 200 
rpm for 24 hours. Unless otherwise noted, each immersion step in the decellularization process 
was subjected to agitation at a speed of 200 rpm. The packaged cartilage was then placed in 0.05 
v/v% Triton X-100, a nonionic detergent, for 3 hours to solubilize and remove proteins.74 Next, 
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the tissue was exposed to 0.0625 KU/mL benzonase nuclease for 12 hours to cleave nucleotide 
chains through enzyme action, and was followed by two one-hour immersions in deionized 
water. The packaged cartilage was then placed in 1 v/v% n-lauroyl sarcosine, an anionic 
detergent, for 12 hours at 21°C and 70 rpm to further solubilize cellular materials. Following 
treatment with n-lauroyl sarcosine, the tissue was immersed in 40% ethanol for 30 minutes, and 
placed in a suspension containing three types of organic ion exchange resins to extract organic 
compounds and remove residual cellular components for 12 hours.74 The packaged cartilage was 
then transferred into a hypertonic saline solution at 21°C and 70 rpm for 2 hours. After 
decellularization, the cartilage-derived ECM remaining in the dialysis tubing was removed and 
freeze-dried. Once dehydrated, the coarse-ground decellularized cartilage was pulverized using a 
cryogenic mill (6775 Freezer/Mill, SPEX SamplePrep, Metuchen, NJ). The resulting DCC 
powder was filtered to ensure that particles in at least one dimension did not exceed 45 µm and 
was stored at -20°C.69 
To assess the extent of decellularization, dsDNA concentrations of coarse-ground native 
cartilage and DCC microparticles were quantitated using a Quant-iT™ PicoGreen® dsDNA 
Assay Kit (ThermoFisher Scientific) and fluorescence plate reader. To prepare samples for 
testing, coarse-ground cartilage and DCC microparticles samples (n=3) were carefully weighed 
and digested in solution containing 4.5 µL/mL papain, 2.8 mg/mL EDTA, 1.8 mg/mL n-acetyl 
cysteine, 2.7 mg/mL potassium phosphate monobasic and 13.7 mg/mL potassium phosphate 
dibasic in distilled water. Next, the samples were vortexed to break up clumps and kept 
overnight at 60°C to achieve complete digestion. Following the recommended assay protocol, 10 
µL of each digested sample and 90 µL of 1X TE Buffer (20-fold dilution of 10 mM Tris-HCl and 
1 mM EDTA) were transferred into wells of a black 96-well plate in triplicate. 100 µL of 200-
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fold Quant-iT™ PicoGreen® reagent was pipetted into each well and was incubated for 5 
minutes at room temperature in dark conditions. After incubation, the fluorescence (480 nm 
excitation and 520 nm emission wavelengths) was measured with a plate reader. In parallel, 
lambda dsDNA standard dilutions ranging from 10 ng/mL to 1 µg/mL dsDNA were prepared in 
1X TE Buffer to generate a 6-point standard curve. The fluorescence of each dilution was 
measured after incubation with the Quant-iT™ PicoGreen® reagent and a linear regression 
model was fit to the data. 
 
Hydrogel Precursor Preparation 
To prepare the radical photoinitiator solution, 5 mg of IRGACURE 2959 (1-[4-(2-
Hydroxyethyoxy)-phenyl]-2-hydroxy-2-methyl-1-propane-1-one, Ciba Specialty Chemicals) was 
mixed with 10 mL of sterile PBS (0.05 w/v% IRGACURE 2959) and heated to 60°C to dissolve. 
To yield 10 mL of UV-crosslinkable hydrogel precursor, 300 mg of PHA, an equimolar amount 
(116.87 mg) of dithiothreitol (DTT), and various amounts of DCC (0, 500, 1000 and 1500 mg) 
were combined with 10 mL of 0.05 w/v% IRGACURE 2959 solution to achieve prescribed PHA 
and DCC concentrations of 3 w/v% and 0, 5, 10 and 15 w/v%, respectively. After an even 
consistency was obtained through vigorous stirring, the hydrogel precursor mixtures were 
centrifuged to remove bubbles, and were protected from light until further use.73 
 
Hydrogel Printing 
3D Printer and Custom Modifications 
An FDM machine (RepRapPro Tricolour Mendel 3D Printer) that supports three motor-
driven Bowden extruders was purchased from RepRap Professional Limited (Bristol, UK), and 
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was assembled according to the manufacturer’s instructions. To expand the printer’s capabilities 
and enable viscoelastic ink deposition through syringe-based extrusion, a 3D-printed syringe 
pump was fabricated and connected to the controller board in place of one of the three filament 
extruders. The main component parts for the linear actuator were printed with polylactic acid 
(PLA, 1.75mm MakerBot PLA filament), and the metal fasteners were purchased from 
Amazon.com and McMaster-Carr (the complete bill of materials can be found on-line at 
http://www.appropedia.org/open-source_syringe_pump). The STL files for the linear actuator 
parts were designed by Michigan Tech’s Open Sustainability and Technology Lab and were 
downloaded from a GitHub repository (https://github.com/mtu-most/linear-actuator).75 A 
modified plunger holder designed by Dylan Lynch was printed to enable front-loading of 10-mL 
syringes onto the linear actuator. The STL file of this component was retrieved from Thingiverse 
(http://www.thingiverse.com/thing:578010). Once assembled, the linear actuator was attached to 
a NEMA stepper motor and connected to the Melzi 2.0 slave controller board. The motor steps 
per mm value was determined through calibration tests and defined in the Marlin firmware. A 
3D-printed mount for the dispensing tip was designed and secured to the motor-controlled printer 
carriage. The syringe pump was suspended above the print bed and tubing and Luer-Lok 
connectors were used to attach the syringe tip to the dispensing tip (Figure 3.2). Lastly, a UV 
lamp (312 nm) was positioned over the print bed to induce the gelation of photocrosslinkable 
extrudates. 
 
Printability Tests and Print Quality Refinement 
The printability of PHA hydrogel precursor solutions with various polymer contents (2, 3 
and 4 PHA w/v%) and molecular weights (100, 500, 700 and 1000 kDa) was examined through 
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extrusion and single-layer print tests using the syringe-based extrusion tool. First, to perform 
extrusion tests, PHA pre-gels were loaded into syringes, coupled to the extrusion tool, and driven 
through the associated tubing and 20-gauge dispensing tip through direct command of the 
stepper motor using Pronterface (host interface) software and the quality of the extrudates were 
assessed. Next, single-layer print tests were performed to evaluate the ability of PHA pre-gels to 
deposit onto the surface of the build plate in continuous filaments and to determine the influence 
of polymer concentration and molecular weight on the shape fidelity and spatial resolution of the 
printed pre-gels. 
 Based on the printability tests, 3 w/v% 1 MDa-PHA pre-gel, which yielded the highest-
resolution single-layer test prints, was selected to investigate the effect of DCC microparticles on 
the printability of the PHA pre-gel. In addition to extrusion and single-layer print tests, 
multilayered print tests were performed to develop a method for printing 3D objects and to 
obtain baseline parameters for printing with 3 w/v% PHA pre-gels containing various 
concentrations of DCC microparticles (0, 5, 10, 15 and 20 w/v%) using the syringe-based 
extrusion tool. Parametric studies were performed to refine the quality of 16-layer 1 cm x 1 cm 
printed hydrogels by adjusting the following parameters in the slicing software: plotting speed, 
plotting volume, retraction length and speed, size and shape of dispensing tip, UV curing time, 
extrusion width and height among others. In addition, certain manual adjustments were made to 
the software-generated G-code script to further optimize the hydrogel printing process. The 
hardware, software, firmware and slicing settings were all manipulated in tandem to manufacture 
3D-printed hydrogels of satisfactory quality. 
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Hydrogel Cast-Molding 
Mold-casted hydrogel groups were made by transferring PHA/DCC pre-gel into a 
rectangular silicone gasket affixed to a glass slide. A second glass slide was used to press-fit the 
mixture into the mold and form a seal with the gasket to create a pre-polymerized slab with a 
defined thickness of 2.25 mm. The slab was irradiated with UV light (312 nm) for 4 minutes on 
each side to allow for uniform crosslinking, and a 4-mm biopsy punch was used to create 
cylindrical samples for further characterization. 
 
Rheological Evaluation of Hydrogel Precursors 
To evaluate the influence of DCC concentration on the rheological behavior of hydrogel 
precursor mixtures, steady state flow and oscillation tests were performed with an AR 2000 
Rheometer (TA Instruments, New Castle, DE) on PHA pre-gels with 0, 5, 10 and 15% DCC 
microparticles. All tests were performed at 25°C to mimic printing conditions using a 20-mm 
crosshatched Peltier plate geometry with a solvent trap and cover to retain hydration and prevent 
light exposure. A truncation gap of 500 µm was used for all the tests. To create flow curves 
(viscosity-shear rate profiles), shear rate sweeps from 0.001 to 1000 1/s were applied to samples 
and viscosity was recorded once steady state was achieved. Next, oscillatory stress sweeps were 
performed from 1 to 500 Pa at 1 Hz to determine the storage and loss moduli in the linear 
viscoelastic (LVE) region (i.e., stress- and strain-independent region) and the magnitude of 
observable yield stresses. Initial frequency sweeps were also conducted to validate that the 
viscoelastic behavior of pre-gels at 1 Hz was linear. 
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Mechanical Characterization 
Uniaxial, unconfined compression tests were performed to determine the compressive 
modulus and strength of PHA/DCC hydrogel groups (n=6) using an RSA III Dynamic 
Mechanical Analyzer (DMA, TA Instruments, New Castle, DE). PHA hydrogels enhanced with 
0, 5, 10 and 15 w/v% DCC microparticles were fabricated by 3D printing and mold-casting 
methods to study the effects of both DCC concentration and fabrication method on hydrogel 
stiffness and strength. To fabricate 3D-printed samples for testing, 12-layered hydrogel slabs 
were printed as described above with layer heights of 0.17 – 0.25 mm (contingent on hydrogel 
formulation) corresponding to overall heights of 2-3 mm. Cylindrical samples were punched out 
of 3D-printed and mold-casted hydrogel slabs with a 4-mm biopsy punch, and were submerged 
in PBS for 24 hours to establish equilibrium swelling. Preceding testing, swollen hydrogels were 
blot-dried, and their mean diameters were measured using digital calipers under 20X 
magnification, and their heights were measured with the DMA. A strain rate of 0.005 mm/s was 
applied to samples until mechanical failure was reached. The slope of the elastic region of the 
stress-strain curve (i.e., 0-10% strain) was calculated as the compressive modulus, and the 
ultimate compressive strength of each sample was taken to be the stress at the point of permanent 
yield (i.e., fracture point). 
 
Swelling Degree 
To determine the swelling ratio of PHA/DCC hydrogel formulations, cylindrical samples 
were punched out of mold-casted hydrogel slabs using a 4-mm biopsy punch. The samples were 
submerged in PBS for 24 hours to establish swelling equilibrium and were carefully weighed 
after blotting to remove excess solution. Each sample was then freeze-dried and their weights 
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were again measured. The swelling ratio (S) of each sample group was determined using the 
equation:  
S = [(WH-WD)/WD],  
where WH is the weight of the fully hydrated gel and WD is the weight of the dehydrated gel. 
Each swelling ratio is reported as the average of six samples. 
 
Cell Harvest and Culture 
Rat bone marrow-derived mesenchymal stem cells (rBMSCs) were harvested from male 
Spraque Dawley rats in strict accordance with an IACUC-approved protocol at the University of 
Kansas. Bone marrow was flushed from the femur bones with sterile PBS containing 1 v/v% 
antibiotic-antimycoctic (anti-anti) and plated in tissue culture flasks containing Minimum 
Essential Medium Eagle Alpha Modification (α-MEM) supplemented with 10 v/v% qualified 
fetal bovine serum (FBS) and 1 v/v% anti-anti. Culture medium was replenished every 2-3 days 
and the cells were subcultured after approximately 80% confluent. Following the first subculture, 
cells were maintained in α-MEM containing 10 v/v% FBS and 1 v/v% penicillin-streptomycin 
(pen-strep) and underwent expansion until passage 4. Unless otherwise stated, all cell culture 
supplies were purchased from Thermo Fisher Scientific. 
 
Hydrogel Disc Preparation and Cell Seeding 
Hydrogel discs were created for insertion into multi-well plates for 2D in vitro studies to 
assess the viability, proliferation and differentiation of seeded rBMSCs. First, all dry materials 
were sterilized with ethylene oxide (Anprolene AN74i Gas Sterilizer, Andersen Products, Haw 
River, NC), and all wet materials were sterilized in an autoclave or with Steriflip® filter units. 
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To prepare hydrogel discs, a small volume of hydrogel precursor mixture was deposited into a 
petri dish and was flattened to a height of 150 µm with a glass slide using spacers. The petri dish 
containing the pre-polymerized disc was then placed under UV light for 4 minutes to achieve 
complete gelation. To aid in the detachment of the polymerized discs, PBS was added to the petri 
dishes before retrieval. The crosslinked discs were washed twice with PBS and were then soaked 
overnight in PBS containing 1 v/v% pen-strep. Prior to cell seeding, the discs were plated into 
multi-well plates and placed under the germicidal UV lamp in the laminar flow hood for 30 
minutes for further disinfection. rBMSCs at passage 4 were trypsinized, resuspended in fresh 
culture media, counted using an automated cell counter (Cellometer, Nexcelom Bioscience) and 
pipetted onto the hydrogel discs for all in vitro experiments. Unless otherwise stated, cell 
cultures were maintained in α-MEM containing 10 v/v% FBS and 1 v/v% pen-strep, which was 
replenished every other day. 
 
Cell Viability 
A LIVE/DEAD Viability/Cytotoxicity Kit for mammalian cells (Molecular Probes, 
Eugene, OR) was used to visualize the viability of rBMSCs cultured on PHA/DCC hydrogels. 
Hydrogel discs (d=22 mm, h=150 µm) were fabricated as described above, plated in 12-well 
plates, and seeded with rBMSCs (100,000 cells/well, passage number 5, n=5). After 24 hours, 3 
days and 10 days of 2D culture, samples were labeled with fluorescent markers to visualize and 
distinguish live- and dead-cell populations within each well. Initially, culture medium was 
removed from the wells and the samples were washed twice with PBS to remove serum and 
reduce the background signal. Next, 300 µL of 0.5 µM calcein AM and 2 µM ethidium 
homodimer-1 in PBS was distributed to each well, incubated for 15 minutes at 37°C and 5% 
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CO2, and protected from light. The samples were again washed with PBS and subsequently 
imaged with a fluorescence microscope (Axio Observer A1 Inverted Microscope and AxioCam 
MRm Fluorescence Camera, ZEISS). The live-cell population was labeled with green-
fluorescent dye and the dead-cell population was labeled with red-fluorescent dye. 
 
Cell Proliferation 
To measure the relative number of viable cells on hydrogels at 1, 3 and 10 days a 
colormetric proliferation assay (CellTiter 96 AQueous One Solution Cell Proliferation Assay, 
Promega, Madison, WI) was performed. PHA/DCC hydrogel discs with diameters of 11 mm and 
heights of 150 µm were prepared as described above, inserted into 48-well plates, and seeded 
with rBMSCs at a density of 40,000 cells/well. Prior to performing the assay, culture media was 
removed and 200 µL of fresh media was added to each well. After 1 hour of incubation in fresh 
media, 20 µL of CellTiter 96 AQueous One Solution Reagent (containing MTS and PES) was 
transferred to each well and the plate was incubated at 37°C and 5% CO2 for 3 hours. After 
incubation, 150 µL of solution from each well was transferred to a 96-well plate and the 
absorbance at 490 nm was read using a plate reader. To obtain the relative cellular metabolic 
activities, absorbance values for each gel formulation were normalized to the mean of the 
corresponding group at day 1. 
 
Cell Differentiation Evaluation 
To determine the potential efficacy of PHA/DCC hydrogel for in situ cartilage 
regeneration, a 4-week in vitro study was conducted to 1) evaluate the expression of 
chondrogenic and osteogenic genes in seeded rBMSCs through quantitative reverse transcriptase 
   
 
  40 
polymerase chain reaction (RT-qPCR) methods and 2) visualize cell organization and cartilage-
specific tissue deposition using histological techniques. PHA/DCC hydrogel discs containing 5, 
10 and 15 w/v% DCC were tested to evaluate the effect of DCC concentration on the type and 
quality of tissue synthesized by rBMSCs. PHA hydrogel without DCC was used as a negative 
control and PHA hydrogel cultured in chondroinductive media containing transforming growth 
factor-beta 3 (TGF-ß3) was used as a positive control. The chondroinductive media used 
throughout the study consisted of α-MEM with 10 ng/mL TGF-ß3 (human recombinant, 
PeproTech), 50 µg/mL ascorbic acid, 1 v/v% pen-strep, 40 µg/mL l-proline, 100 µM sodium 
pyruvate, 0.1 µM dexamethasone (MP Biomedicals), 1 v/v% insulin-transferrin-selenium and 
1% non-essential amino acids, and is known to be a potent inducer of chondrogenesis and 
hyaline-like cartilage formation in progenitor cells.76 Hydrogel discs (d=15.5 mm, h=150 µm) 
were fabricated to fit into 24-well plates and all wells were seeded with 40,000 rBMSCs. 
 
Relative Gene Expression Quantitation 
RT-qPCR was performed to investigate the relative expression levels or fold changes in 
the expression of chondro- and osteogenic genes in rBMSCs cultured on PHA/DCC hydrogel 
discs (n=6) at prescribed time points of 1, 14 and 28 days. First, media was removed from the 
well plates and samples were washed twice with PBS. Following an established protocol, mRNA 
was purified from the rBMSCs using an RNeasy Mini Kit (Qiagen, Hilden, Germany). To 
measure the concentration and purity of the isolated mRNA, a NanoDrop 2000 
Spectrophotometer (Thermo Fisher Scientific) was used. mRNA samples with absorbance ratios 
(A260/A280) within the range of 1.8-2.2 were considered to be of acceptable purity and were 
reverse-transcribed to complementary DNA (cDNA). Reverse transcription (RT) reactions were 
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carried out using a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster 
City, CA) in a thermal cycler (Eppendorf Mastercycler ep Gradient S). TaqMan® Gene 
Expression Assays and TaqMan® Fast Universal PCR Master Mix (2x), No AmpErase UNG 
(Applied Biosystems, Thermo Fisher Scientific) were used to amplify the cDNA templates and 
detect the following genes of interest: glyceraldehyde phosphate dehydrogenase (GAPDH, Assay 
ID: Rn01775763_g1), sex-determining region-Y-box 9 (SOX9, Assay ID: Rn01751070_mH), 
collagen type II alpha-1 chain (COL2A1, Assay ID: Rn01637087_m1), aggrecan (ACAN, Assay 
ID: Rn00573424_m1), and collagen type I alpha-1 chain (COL1A1, Assay ID: 
Rn01463848_m1). The assays were run in a thermal cycler using ‘Fast’ thermal cycling 
conditions, and the expression levels of target genes were normalized to GAPDH, the 
endogenous control. Each sample was assessed in duplicate. The comparative CT method was 
used to quantitate the expression levels of target genes normalized to the endogenous control and 
relative to the negative control group at day 1, also known as the reference sample. Results are 
reported as fold changes in gene expression from the negative control group at day 1. 
 
Histological Examination 
Histological staining was used to resolve the spatial organization and ECM deposition of 
rBMSCs on PHA/DCC hydrogels in vitro. At 1, 14 and 28 days, culture media was removed 
from the wells and samples were fixed in 10% neutral buffered formalin overnight at 4°C. After 
the fixative was discarded, the wells were washed twice with PBS. To visualize the morphology 
and distribution pattern of cells, hematoxylin and eosin (H&E) solutions were used to stain 
nuclei and cellular cytoplasm, respectively. Briefly, samples were exposed to Hematoxylin QS 
(H-3404, Vector Laboratories, Burlingame, CA) for 5 minutes and then washed with 1 v/v% HCl 
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in 70 v/v% ethanol. Next, samples were exposed to bluing reagent (Richard-Allan Scientific 
Signature Series Bluing Reagent, Thermo Fisher Scientific) for 5 minutes, washed with 
deionized water, and exposed to 0.25 w/v% eosin for 20 seconds. The wells were washed twice 
with deionized water, and incubated in PBS at 4°C for one week prior to imaging to reduce the 
intensity of the stain. Additionally, Safranin-O and Fast Green dyes were used to stain 
proteoglycans red and non-collagen sites green for contrast. Initially, formalin-fixed samples 
were immersed in a 1:10 dilution of Hematoxylin QS for 4 minutes and washed with deionized 
water. Next, 0.04 w/v% Fast Green was applied to each sample for 4 minutes, 0.1 v/v% acetic 
acid was applied for 30 seconds, and 0.05 w/v% Safranin-O was applied for 4 minutes. Samples 
were washed with deionized water and imaged after soaking in PBS for one week. To further 
visualize cell distribution and organization, fluorescence microscopy was performed, and Alexa 
Fluor® 488 Phalloidin and DAPI (4',6-Diamidino-2-Phenylindole, Dilactate) dyes were used to 
label F-actin and cell nuclei, respectively. First, formalin-fixed samples were washed twice with 
PBS and immersed in 0.1% Triton X-100 (IBI Scientific) in PBS for 20 minutes. After two 
washes with PBS and in dark conditions, phalloidin dye was diluted in 0.1% BSA (1:40 dilution) 
and was added to wells for 45 minutes. Samples were washed twice with PBS and then soaked in 
DAPI dilactate in PBS (1:100 dilution) for 5 minutes. Samples were washed with PBS and 
immediately imaged under both UV and blue excitation. All images were acquired with a ZEISS 
Axio Observer A1 inverted microscope equipped with ZEISS AxioCam color and fluorescence 
cameras. 
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Statistical Analysis 
Statistical analyses were carried out with R statistical software. For single-factor 
experiments (e.g., hydrogel formulation), one-way analysis of variance (ANOVA) was used to 
determine whether statistically significant differences were present between mean treatment 
effects. For two-factorial experiments (e.g., hydrogel formulation and fabrication method), two-
way ANOVAs were conducted to test omnibus hypotheses. For pairwise comparisons, 
simultaneous Tukey’s Honestly Significant Differences (HSD) post-hoc tests were performed 
with 95% family-wise confidence levels. Observed differences among treatment effects were 
considered statistically significant when their calculated p-value was less than 0.05. To infer 
statistical significance (p < 0.05) for RT-qPCR experiments, the pre-transformed threshold cycle 
normalized to the internal control gene and negative control group (ΔΔCt) was selected as the 
response variable in the two-way ANOVA models and subsequent Tukey’s HSD tests for each 
gene of interest. Quantitative results are presented as the mean value ± standard deviation. 
 
RESULTS AND DISCUSSION 
Material Characterization 
HA was chemically modified with alkene functionalities to enable hydrogel formation 
through photocrosslinking. To this end, pentenoate groups were grafted onto the HA backbone 
through esterification of the primary hydroxyl groups. HNMR spectroscopy was performed to 
confirm successful derivatization of HA and to determine the degree of functionalization (DF). 
The resonance signals at around 2.25, 2.5, 5.0 and 7.5 ppm are indicative of HA derivatization 
and correspond to the hydrogen atoms located along the chain of the pentenoate group (Figure 
3.3). To calculate the DF, peaks located at around 5.75 ppm and 1.75 ppm of the NMR spectra 
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were integrated, corresponding to hydrogen atoms located on the pentenoate double bond 
(labeled HC) and hydrogen atoms located on the acetyl group of the HA molecule (labeled H2’’), 
respectively. The integrated intensities were compared to obtain the ratio of pentenoate groups to 
hyaluronic acid molecules. The DF from the representative spectra shown in Figure 3.3 was 
determined to be 22% pentenoate groups per HA molecule, and the DF for all batches of PHA 
used in the current study ranged from 22-28%. After chemical modification, PHA was reacted 
with a dithiol compound (DTT) in photoinitiator (Irgacure 2959) solution to form thioether 
bridges between pendant pentenoate groups to form a stable crosslinked network through 
photoinduction. Based on observation, PHA pre-gels underwent complete gelation within 
approximately 3 minutes of UV exposure, echoing the findings of Mergy et al.73 The 
crosslinking density of the hydrogel is limited by the DF of PHA, which is modulated by the 
molar ratio of pentenoate anhydride to hyaluronic acid in the esterification reaction. Though DF 
was not varied in the current study, crosslinking density has been shown to have opposing effects 
on the printability and tissue-forming capacity of hydrogels.67, 77 Since the mesh size or effective 
porosity of the hydrogel network is decreased when the degree of crosslinking is increased, the 
diffusion rate of nutrients is lower and tissue ingrowth is more obstructed at higher crosslinking 
densities.77 In contrast, the mechanical stability and therefore printability of the hydrogel is 
enhanced when highly crosslinked. Therefore, the crosslinking density of PHA hydrogel should 
be optimized in the future to balance these antagonistic effects.  
The objective of decellularization was to create cartilage-derived particles that were both 
chondroinductive and immunoneutral for incorporation into PHA hydrogels. Toward this 
objective, porcine cartilage was decellularized to remove cellular components and associated 
epitopes to reduce the risk of inflammatory or adverse immune responses, while retaining the 
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physicochemical characteristics of the ECM to preserve bioactive cues, which have been shown 
to potentiate chondrogenic differentiation of progenitor cells.69 Through the use of specific 
enzymes, detergents, osmotic shock, and physical fragmentation, the dsDNA content was 
reduced in porcine-derived articular cartilage as quantified through Quant-iT PicoGreen assays 
(Figure 3.4). Cryoground native cartilage contained 1023 ± 31 ng dsDNA per mg dry material 
and cryoground DCC contained 242 ± 26 ng dsDNA per mg dry material. The efficiency of the 
method, defined as the percent decrease of dsDNA content in cryoground cartilage pre- and post-
decellularization, was determined to be 76.4%. Currently, there are no standardized or evidence-
based guidelines in place to define the decellularization endpoint, nonetheless by convention, 
tissues with less than 50 ng dsDNA per mg dry material are regarded as decellularized.74 Though 
a significant decrease in dsDNA was observed in the DCC, the decellularization method did not 
reduce dsDNA to this conventional threshold value, and therefore decellularization was 
considered mild. Though not substantiated in the present study, Sutherland et al.69 observed 
GAG and collagen retention using an identical decellularization protocol.  
Since the tissue derivatives are xenogeneic, cellular remnants may contain the alpha-Gal 
epitope, which has caused immune-regulated rejection of porcine implants in primates.78, 79 
However, Daly et al.79 found that decellularized tissue did not elicit adverse immune responses 
in the host even though antibody levels for the alpha-Gal epitope were elevated. Therefore, 
modifications to the decellularization protocol should be investigated to effectively and 
reproducibly 1) reduce dsDNA content to acceptable levels (i.e., <50 ng dsDNA per mg of dry 
material) to prevent immunogenicity in the recipient, and 2) retain biochemical and structural 
cues to promote cartilage growth.  
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Hydrogel Printing 
PHA hydrogel precursor solutions with various polymer contents (2, 3 and 4 w/v%) and 
molecular weights (100, 500, 700 and 1000 kDa) were prepared, loaded into syringes, and 
extruded through the custom-built syringe-based extrusion tool. All 2 and 3 w/v% PHA pre-gels 
as well as 4 w/v% 100 kDa-PHA pre-gel were capable of motor-driven extrusion through the 
dispensing tip. In contrast, 4 w/v% pre-gels prepared with 500, 700 and 1000 kDa PHA caused 
the extrusion tool to jam, and the motor was incapable of driving these pre-gels through the 
associated tubing and dispensing tip. Though extrudable, the 4 w/v% 100 kDa-PHA pre-gel was 
nonuniformly dispensed, and caused sporadic blockages in the dispensing tip, resulting in 
unpredictable sputters. All 4 w/v% PHA pre-gels were difficult to prepare at room temperature, 
and homogenous solutions could not be fully achieved, which may indicate that the solubility 
limits of PHA in PBS were reached or exceeded. Therefore, 4 w/v% PHA pre-gels were 
considered unsuitable for printing. 
The consistency of the extrudates was found to be dependent on both PHA molecular 
weight and content of the pre-gel. 2 and 3 w/v% 100 kDa-PHA pre-gels extruded out of the 
dispensing tip in fluid-like drops. 2 and 3 w/v% 500 kDa-PHA as well as 2 w/v% 700 kDa-PHA 
pre-gel formulations extruded as viscous globules, and 3 w/v% 700 kDa-PHA, and 2 and 3 w/v% 
1000 kDa-PHA pre-gel formulations were extruded as continuous filaments. An image of the 
extrusion of 3 w/v% 1000 kDa-PHA pre-gel as a stable, continuous filament is shown in Figure 
3.5A. 
 With the exception of 4 w/v% PHA pre-gels, single-layer print tests were performed to 
test the printing capabilities of all formulations, in which a series of connected parallel lines were 
deposited with homogenous filament spacings of 0.2 mm (Figure 3.5C). Not including the 3 
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w/v% 700 and 1000 kDa-PHA pre-gels, all tested pre-gel formulations were deposited onto the 
print bed in an irregular fashion. For example, 2 and 3 w/v% 100 kDa-PHA pre-gels had no 
shape fidelity once deposited, and the extrudates immediately coalesced into droplets, resulting 
in amorphous prints bearing no resemblance to the CAD model. The print quality improved as 
both molecular weight and polymer concentration was increased. Accordingly, 3 w/v% 1000 
kDa-PHA pre-gel generated the highest-resolution prints, containing deposited filaments that 
possessed structural integrity and exhibited minimal expansion and flattening. Results from these 
preliminary printability tests are summarized in Figure 3.5B, in which each formulation is 
classified as ‘unextrudable’, ‘irregular’ or ‘printable’. In addition, representative images of 
printable and irregular hydrogel deposits are shown in Figure 3.5C. 
Due to exhibiting the highest observable print quality, 3 w/v% 1000 kDa-PHA pre-gel 
was selected to investigate the influence of DCC microparticles on the rheological properties and 
printability of PHA pre-gel. The printing capability of PHA pre-gels with 5, 10, 15 and 20 w/v% 
DCC particles was investigated. All pre-gel formulations, apart from the 20 w/v% DCC group 
were considered printable, as they could be deposited in filamentous strands to form defined 
structures in a layer-by-layer fashion. The 20 w/v% DCC group however was too viscous for 
motor-driven extrusion and could not be forced out of the syringe and into the associated tubing. 
The CAD model and corresponding printer tool path for the multilayered print tests are shown in 
Figure 3.6A, and the gross morphology of the fully realized 16-layered, 3D-printed 1 cm x 1 cm 
hydrogel structures with 0, 5, 10 and 15 w/v% DCC microparticles can be viewed in Figure 
3.6B. All hydrogel structures agreed with the dimensions of the model as measured by digital 
calipers, and model equivalence was shown to depend on the positioning accuracy of the printer, 
the exactness of the mechanical calibrations, printing parameter refinement, and the rheological 
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properties of the material. Filament spacing was adjusted to generate hydrogel structures with no 
void spaces to resemble articular cartilage for joint resurfacing applications. The print quality of 
the hydrogel structures was optimized by manipulating the following printing parameters in the 
slicing software: plotting speed, plotting volume, extrusion width, extrusion height, and various 
retraction parameters (length, speed, etc.). Additionally, custom G-code was added to the script 
after every two layers to move the 3D-printed material under the UV light source for 90 seconds 
to stabilize the structure through photocrosslinking before starting the next two layers. 
Though 0, 5, 10 and 15 w/v% DCC groups were printable, all of the 3D-printed 
rectangular prisms exhibited different appearances and structural qualities. For example, 
extruded filaments in the 0 w/v% DCC group exhibited higher degrees of filament expansion and 
flattening as well as interfilament fusion, creating a smoother macroscopic appearance. In 
contrast, the 15 w/v% DCC group exhibited a higher degree of filament resolution, where the 
extruded filaments though fused could be distinguished and the structure appeared multilayered 
in nature. The 5 and 10 w/v% DCC groups exhibited properties that resided somewhere in 
between, containing both smooth and striated appearances. 
 
Rheological Evaluation 
To investigate the viscoelastic behavior and structural properties of the hydrogel 
precursor mixtures, steady-state flow and oscillation tests were performed. First, steady-state 
viscosity of pre-gels was measured over a range of shear rates and representative steady-state 
flow curves are shown in Figure 3.7A. All pre-gel formulations (i.e., 0-15% DCC groups) 
exhibited shear-thinning behavior, where viscosity was high at low shear rates and decreased 
with increasing shear rate as the polymer chains disentangled and intermolecular forces were 
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overcome.67 For example, the viscosity of the pre-gels at an ultra-low shear rate of 0.001 s-1 
across all pre-gel groups ranged from 260-1700 Pa-s, but as the shear rate approached 1000 s-1, 
viscosity measurements among the groups all decreased to ~1 Pa-s. In addition, viscosity 
measurements taken at low shear rates in the range of 0.001 to 0.01 s-1 were higher in magnitude 
for pre-gels containing higher concentrations of DCC microparticles. 
To evaluate the storage modulus (G’) and loss modulus (G’’) of the material, oscillation 
tests were performed on the PHA/DCC pre-gels by applying a stress sweep from 1 to 500 Pa. 
The rheological properties in the linear viscoelastic (LVE) region were determined by averaging 
the oscillatory measurements of G’ and G’’ taken at applied shear stresses of 1-10 Pa, and are 
reported in Figure 3.7C. G’ and G’’ were shown to increase with increasing DCC concentration, 
and for the 10 and 15% DCC groups G’ was higher than G’’ indicating that the elastic properties 
were dominant at low shear stresses. In addition, the G’ and G’’ curves for these formulations 
had crossover points, where the G’ and G’’ were equivalent. The modulus crossover point is 
where the viscoelastic behavior of the pre-gel transitions from solid-like to fluid-like. The 
imposed shear stress at this point, called the yield stress, represents the stress magnitude that 
must be exceeded to overcome the intermolecular and interparticle forces of the material to 
induce flow. The 0 and 5% DCC groups did not possess yield stresses as they exhibited fluid-like 
properties even at low shear stresses (G’’ > G’). The yield stresses of the 10 and 15% DCC 
groups were determined to be 142 ± 18 and 231 ± 51 Pa, respectively (Figure 3.7B).  
The rheological properties of printable hydrogel inks are not widely reported in literature, 
though certain rheological properties have been shown to greatly enhance the printing resolution 
of viscoelastic materials.67 Shear-thinning behavior and the presence of a yield stress are two 
such properties. Shear-thinning behavior is ideal because in the absence of shear stress, the 
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hydrogel ink possesses high viscosity, but as the shear stress increases, polymer chains 
disentangle and the material flows more easily. This shear-thinning behavior is an important 
property so that hydrogel ink can be more easily driven through the extrusion tubing and tip due 
to apparent decreases in viscosity. Once deposited, shear stress is reduced and the viscosity again 
increases, providing more resistance to flow, which promotes shape retention. Another property 
that significantly impacts hydrogel ink printability is yield stress. Materials with yield stresses 
act as elastic solids when interparticle and intermolecular forces within the hydrogel matrix are 
stronger than applied stresses. When the applied stress is greater than the yield stress, the 
structure deforms and begins to flow. Therefore, yield stress enhances the shape fidelity and 
resolution of printed pre-gels, and prevents drips from the nozzle tip when extrusion is halted, 
while still allowing material to be dispensed when commanded.  
Rheological measurements of the pre-gels were consistent with the printability tests 
performed in the current study. As previously described, 3D-printed hydrogels manufactured 
with 0 and 5% DCC groups were more amorphous in nature, as the deposited filaments tended to 
spread prior to UV curing. The 10 and 15% DCC groups were visibly striated, with stratified 
layers and visible filament deposition patterns, demonstrating that the presence of a yield stress 
has an impact on the resolution of the printed structure. Of note, the stepper motor that drives 
hydrogel extrusion occasionally jammed when printing with 15% DCC pre-gels, which likely 
represents the maximum allowable viscosity that the printer can extrude. In addition to shear-
thinning and the presence of a yield stress, rapid photocrosslinking of deposited PHA/DCC pre-
gels enabled immediate structural stabilization of printed layers to enhance resolution and 
provide a solid foundation for the next layer of the print. 
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Mechanical Evaluation 
To assess the mechanical robustness of 3D-printed PHA/DCC hydrogels, compressive 
mechanical testing was performed to investigate the effect of DCC concentration as well as the 
effect of the fabrication method on hydrogel stiffness and strength. The mechanical properties of 
3D-printed 3 w/v% PHA hydrogels containing 0, 5, 10 and 15 w/v% DCC particles with no 
voids were compared to mold-casted equivalents to determine whether 3D printing impacted the 
mechanical performance of the hydrogels. In fact, since mechanical failure typically occurs at 
scaffold interfaces, one concern was that the layer-by-layer assembly of 3D-printed hydrogels 
would reduce the mechanical robustness and therefore viability of the hydrogel to serve as a 
scaffold for cartilage regeneration. All mechanical testing was performed on hydrogel samples in 
their equilibrium swelling state to determine the stiffness and strength that they would exhibit in 
physiological conditions. The compressive modulus or mechanical stiffness, defined as the slope 
in the elastic region of the stress-strain curve, of 3D-printed gels was found to significantly 
increase with the addition of DCC particles. 5, 10 and 15% DCC groups had compressive moduli 
greater than the 0% DCC group (p < 0.05), though no statistical differences among DCC-bearing 
hydrogels could be confirmed (Figure 3.8A). The compressive strength, defined as the stress 
associated with fracture, of the 3D-printed 15% DCC group was significantly higher than the 
3D-printed group without DCC particle suspensions (Figure 3.8B). Specifically, the compressive 
modulus and strength was highest for the 15% DCC group, which was determined to be 6.8 ± 0.6 
kPa, and 70.3 ± 10.4 kPa, respectively. Comparisons of 3D-printed and mold-casted samples 
revealed that the fabrication method had no significant effect on the mechanical properties of the 
hydrogels; an important finding that validates 3D printing as a viable alternative to traditional 
mold casting.  
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Since cartilage is a load-bearing tissue, the hydrogel must be able to withstand 
physiological loads and loading patterns. Therefore, hydrogel stiffness, which also regulates stem 
cell differentiation, must be matched to that of native cartilage to resist physiological loads and 
provide relevant mechanical cues to promote hyaline-like cartilage production. Native cartilage 
possesses approximate stiffness values ranging from 240 - 1360 kPa depending on the location, 
zone and mechanical testing parameters.80, 81 Since the compressive modulus of PHA/DCC 
hydrogels are orders of magnitude smaller than that of native articular cartilage, stiffening and 
strengthening strategies should be explored to improve the mechanical properties. Hydrogel 
reinforcement strategies such as co-printing internal polymeric cages, and embedding melt-
printed lattice structures in mold-casted hydrogels among others have been investigated and have 
reportedly achieved stiffness values similar to native articular cartilage.70, 82 
 
Swelling Behavior 
The swelling ratios of pre-swollen to swollen hydrogels after incubation in PBS for 24 
hours were calculated for each PHA/DCC hydrogel formulation by measuring the percent 
increase in the wet sample weight over the dry sample weight. The differences in swelling ratio 
between hydrogels in their equilibrium swelling state compared to their pre-swollen state were 
substantial. In particular, the 0, 5, 10 and 15 w/v% DCC groups increased 11.2-, 10.6-, 9.6- and 
6.5-fold (p < 0.05), respectively after equilibrium solvent absorption. While hydrogel swelling is 
advantageous to resident cells by increasing the rate of diffusion of nutrients into and cellular 
waste out of the hydrogel matrix, it is also pertinent to moderate swelling as much as possible 
insofar as to ensure that 3D-printed hydrogels retain physiologically relevant dimensions to be 
effective in cartilage tissue engineering applications.83 The incorporation of DCC particles was 
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shown to reduce the mass-swelling ratio, and at least in part mitigate increases in volume caused 
by swelling (Figure 3.9). 10 and 15% DCC groups had lower swelling ratios than 0 and 5% DCC 
groups (p < 0.05), which indicate that the hydrogel microstructure is enhanced by the addition of 
DCC through increased interparticle forces, which provide resistance to deformation and help 
restrain the osmotic influx of solvent. Ideally, water content in the hydrogel should resemble that 
of native cartilage to enable efficient nutrient transport and natural biological processes.81 The 
water content in native articular cartilage ranges from 65 w/w% to 80 w/w%, corresponding to 
respective mass-swelling ratios of 1.86 to 4.84 Based on swelling behavior alone, the 15% DCC 
group would be best suited for hydrogel fabrication via 3D printing to minimize the changes in 
shape and size when placed in hydrated conditions. Still, design strategies would need to account 
for swelling-associated shape distortion in order to fabricate patient-specific constructs that 
replicate and regenerate cartilage defects with anatomical precision. 
 
Cell Viability and Proliferation 
To demonstrate cell viability, rBMSCs were cultured in 2D for 10 days, and 
fluorescence-based LIVE/DEAD assays were carried out at predefined intervals to observe live 
and dead cell populations on the hydrogel discs. Microscopic images are displayed in Figure 
3.10A, where live cells are depicted in green and dead cells are depicted in red. The images 
reveal an abundance of live cells with fibroblastic morphologies, and in comparison very few 
dead cells were observed. Cell proliferation was observed as evidenced by the sparse distribution 
of cells at day 1 and full coverage on hydrogel surfaces at day 10. Viability and proliferation 
seemed to be supported to similar extents by all hydrogel formulations. To quantitatively 
evaluate the influence of DCC particle concentration on cell proliferation, the metabolic activity 
   
 
  54 
of rBMSCs on each sample was measured by performing MTS proliferation assays at the same 
time points. As shown in Figure 3.10B, there were no significant increases in cell number from 
day 1 to day 3 for all hydrogel formulations. There was, however, an increase in cell number in 
day 10 compared to the prior time points (p < 0.05). Respectively, 0, 5, 10 and 15% DCC groups 
had 26, 39, 50 and 48% increases in relative cell number from day 3 to day 10, though no 
significant differences were detected in cellular proliferation among hydrogel formulations. 
Therefore, the addition of DCC microparticles did not affect cellular proliferation with statistical 
significance.  
 
Cartilage-Specific Gene Expression 
SOX9, COL2A1 and ACAN expression levels were quantified through RT-qPCR to 
evaluate the regulation of these chondrogenic genes in cells cultured on the PHA/DCC 
hydrogels. COL1A1 levels were also quantified as an indicator for hypertrophy or osteogenic 
differentiation. The relative expression levels of each chondrogenic and osteogenic gene at each 
time point are shown in Figure 3.11. 
SOX9 expression was upregulated in all groups at weeks 2 and 4 compared to the 
calibrator control group (i.e., 0% DCC at day 1). In 0% DCC samples, SOX9 expression was 
2.2-fold higher in week 2 and 3.5-fold higher in week 4 than on day 1 (p < 0.05). SOX9 levels 
increased by 2.6- and 2.5-fold in 5% DCC samples in weeks 2 and 4, respectively, while 10% 
DCC samples experienced a transient yet significant decrease in SOX9 expression (11.9% 
reduction) in week 2 followed by a 3.1-fold increase in week 4 (p < 0.05). Notably, 15% DCC 
samples had higher SOX9 expression levels than all other groups in weeks 2 and 4, levels which 
increased by 5.5-fold in week 2 and 8.4-fold in week 4 compared to day 1 (p < 0.05). There was 
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a significant decrease in the expression of SOX9 from day 1 to week 2 in the positive control 
group (i.e., 0% DCC + TGF-ß3) followed by an apparent 3.2-fold increase in week 4. Positive 
control samples had higher SOX9 expression levels relative to other groups at day 1 by factors of 
2.3 to 5.2. COL2A1 expression did not significantly change throughout the study, though the 0% 
DCC group had significantly higher COL2A1-specific mRNA levels in week 4 compared to 
week 2 or day 1. Additionally, COL2A1 expression in week 4 was higher in 0% DCC samples 
than 5, 10 and 15% DCC samples. Likewise, ACAN levels did not significantly change 
throughout the study, though ACAN levels in the positive control group experienced a transient 
decrease in week 2. COL1A1 expression levels also remained stable throughout the culture 
period, with the exception of significant differences between the positive control group and all 
other groups in week 4, where the positive control group had a relative COL1A1 level of 3.6, and 
the other groups had relative levels ranging from 0.5 to 1.3. 
Overall, the results indicate that DCC enrichment of PHA hydrogel may induce 
chondrogenesis. The most compelling evidence for DCC-dependent chondrogenesis was that the 
15% DCC group had more elevated SOX9 levels than all experimental groups including the 
positive control group at each time point. SOX9 is required for chondrogenesis and controls 
transcription of COL2A1 and ACAN among other cartilage-specific matrix proteins by binding 
to regulatory sequences on introns.85 Though increases in COL2A1 and ACAN levels were 
expected, chondrogenesis is a multi-step process, so the rates of transcription of COL2A1 and 
ACAN genes may have heightened if the culture time was extended and SOX9 expression levels 
were sustained. Alternatively, the lack of gene upregulation of ECM proteins COL2A1 and 
ACAN may have been due to the 2D culture conditions. The cells may have overpopulated the 
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hydrogel surfaces, minimizing their direct contact with the DCC microparticles, which present 
cell-instructive signals. 
The only group that experienced higher COL2A1 expression was the negative control 
group in week 4, though in general the expression levels remained unchanged. COL1A1, an 
osteogenic gene, was also tested to ensure that cells were not undergoing hypertrophy or 
osteogenic differentiation. As expected, COL1A1 expression remained stable. The incorporation 
of DCC in PHA hydrogel, specifically at a concentration of 15 w/v%, may alone be sufficient to 
direct differentiation of rBMSCs toward a chondrogenic lineage, since SOX9 levels were higher 
in 15% DCC samples than in positive control samples, indicating that 15% DCC hydrogels 
outperformed exogenous TGF-ß3 and dexamethasone supplementation. Though mainly positive, 
the results herein may be difficult to reproduce due to batch variations in PHA and DCC 
microparticles. Batch properties are reliant on the degree of pentenoate functionalization, 
cartilage donor, decellularization efficiency, retention of ECM ligands, and homogeneity of the 
DCC suspensions in the hydrogels.  
 
Histological Evaluation 
Histology was performed to examine hydrogel groups at days 1, 14 and 28 to confirm 
cartilage-specific tissue formation. H&E staining was performed to visualize cell morphology 
and distribution. The hematoxylin dye stained cell nuclei deep purple, and the eosin dye was 
used to counterstain cytoplasm. Figure 3.12 shows the images of H&E staining taken at 20x 
magnification of all hydrogel groups during the 4-week culture. Cells with fibroblastic 
morphologies were observed in the 0% DCC and 0% DCC + TGF-ß3 (positive control) groups 
and visibly multiplied over time. The addition of DCC particles made it difficult to distinguish 
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nuclei and other cellular structures since it increased hydrogel opacity. Furthermore, background 
staining of the hydrogel was observed making it all the more difficult to discern structures of 
interest.  
Safranin O staining along with Fast Green and weak hematoxylin counterstaining was 
performed to stain GAGs orange, non-collagenous proteins green, and cell nuclei deep purple, 
respectively (Figure 3.13). Similar to H&E staining, nuclei and ECM components were difficult 
to perceive on hydrogels containing DCC particles. Furthermore, Safranin O dye selectively 
binds to GAGs such as hyaluronic acid so background staining was predictably evident. 
However, the 5, 10 and 15% DCC groups in week 4 exhibited regions of high-intensity regions 
of orange-red, regions, which were not seemingly present in day 1 and week 2 samples. 
Furthermore, the 15% DCC group seemed to have larger and more intense areas of red, 
potentially indicating that DCC particles positively influence chondrogenesis and as a result 
GAG production. Fast Green staining seemed to selectively stain the cartilage-derived particles 
in the PHA/DCC hydrogel groups, revealing that DCC particles were stably incorporated into the 
crosslinked HA matrix throughout the culture period.  
DAPI and phalloidin fluorescent dyes were employed to better resolve cell morphology 
and organization on the opaque hydrogels (Figure 3.14). Cells in the 15% DCC + TGF-ß3 group 
seemed sparser than in the other groups at weeks 2 and 4, though no quantitative methods were 
performed to determine relative cell numbers during the 4-week study. The cells in all groups 
adopted a spread, fibroblastic morphology, and with the exception of the positive control group, 
cells were confluent by week 2 and appeared to increase in number over time. 
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CONCLUSIONS 
 The results herein provide preliminary data as to the efficacy of PHA hydrogels enriched 
with DCC particles for 1) 3D printing with an open-source, syringe-based extrusion tool and 2) 
stimulating chondrogenesis and cartilage formation in vitro. After preliminary printability tests, 
hydrogel fabricated with high-molecular weight PHA (1 MDa) and a 3 w/v% polymer content 
was selected as the ideal dispersion medium for DCC microparticles. The incorporation of DCC 
enhanced the rheological properties of PHA pre-gel for 3D printing, endowing the pre-gel with a 
yield stress and higher viscosity. The presence of a yield stress strongly correlated to the 
resolution of the 3D-printed hydrogels, as the interparticle and intermolecular forces provided 
structure to the fluid at low or negligible shear stresses, which improved the shape fidelity of 3D-
printed pre-gel filaments. The mechanical stiffness and strength of PHA hydrogel were also 
enhanced by the addition of DCC microparticles. Furthermore, there were no statistical 
differences in mechanical properties between 3D-printed and mold-casted hydrogel groups, 
indicating that hydrogel printing is a viable fabrication method for creating patient-specific 
scaffolds. DCC microparticles also mitigated the swelling of PHA hydrogel, which is beneficial 
for shape preservation in physiological conditions. Lastly, the PHA/DCC hydrogels supported 
rBMSC survival and proliferation, and have the potential to promote chondrogenesis as 
evidenced by fold-increases of the chondrogenic gene, SOX9, and increases in GAG production 
especially at higher concentrations of DCC microparticles.  
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Chapter 4: Early Prototyping of Patient-Specific Scaffolds for Mandibular Condyle 
Regeneration 
INTRODUCTION 
Temporomandibular disorders (TMDs) affect an estimated 30 million individuals 
nationwide, and are characterized by pain and dysfunction in the temporomandibular joint (TMJ) 
and surrounding musculature.86 Many patients with TMDs experience a reduced ability to carry 
out functions such as talking, chewing and laughing, which greatly diminishes quality of life. 
Patients with late-stage disorders often require TMJ reconstruction with either costochondral 
grafts or alloplastic prostheses to alleviate severe pain and improve joint movement. However, 
TMJ replacements only function to relieve symptoms rather than restore health to the joint. 
Furthermore, the long-term stability of the replacements is unpredictable, and there is a high 
incidence of failure necessitating additional surgeries. 
To improve clinical outcomes and expand the range of treatment options for late-stage 
patients, tissue engineering therapies that aim to “restore, maintain and improve tissue function” 
hold great promise.87 Of critical importance for tissue engineering is the generation of scaffolds, 
which serve to support and instruct resident cells to grow and reproduce the envisioned tissue.88 
Scaffold composition and microarchitecture influences cell behavior and differentiation through 
physical and chemical signaling mechanisms and can be engineered to stimulate different types 
of tissue growth within discrete regions. In particular, scaffolds that aim to mimic the 
complexities of native extracellular matrix (ECM) have been shown to elicit enhanced tissue-
specific regeneration. In addition, scaffolds must be biodegradable, so that as cells proliferate 
and secrete ECM, the formation of congruent tissue is not impeded. Scaffolds must also have 
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interconnected pores to allow for cell infiltration, homogenous cell distribution, and efficient 
nutrient and waste exchange.88 
Recently, three-dimensional (3D) printing technologies have been implemented in the 
field of tissue engineering to enable the digital design and manufacture of more sophisticated 
scaffold-based therapies.88, 89 3D printing uses motorized, multi-axis deposition tools, to extrude 
material in defined patterns, layer upon layer, to yield specific 3D geometries. This technology 
allows researchers to not only customize the external macrostructure, but also the internal 
microstructure of scaffolds, which greatly influences cell differentiation and the mechanical 
properties. Compared to conventional scaffold fabrication techniques, 3D printing offers 
significant benefits in that interconnected pore structures can be carefully designed and 
reproduced to facilitate specific cell-material interactions to more predictably control cell 
behavior. The internal pore structures of scaffolds fabricated by conventional techniques on the 
other hand, rely on the randomness of the fabrication process, and are not controllable to a large 
degree. Furthermore, 3D printing technology in combination with medical imaging enables the 
creation of scaffolds with patient specificity to restore the anatomic structure of defective tissue 
as well as the spatial patterning of structural and biological cues to induce site-specific tissue 
formation. 
Computational control over scaffold features, which dictate cell behavior such as cell 
growth and differentiation, is therefore highly beneficial especially in multi-tissue or interfacial 
tissue engineering applications. Biological joints are particularly demanding to regenerate since 
they are composed of bone and cartilage tissues, which differ in cell type, ECM components, 
ECM organization and mechanical properties. In addition, joints have an interfacial region that 
exhibits transitional characteristics and serves to stabilize and unite the two disparate tissues. To 
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produce osteochondral scaffolds for joint regeneration, multiple printing tools can be combined 
to deposit multiple materials, even within the same layer, to produce both discrete and integrated 
regions within the scaffold. 3D printing therefore has the potential to integrate materials in multi-
tissue scaffolds in a controlled manner to avoid delamination, a recurring problem in 
osteochondral tissue engineering.90 
To address the need for further development of tissue engineering therapies for biological 
joint repair such as the mandibular condyle, extrusion-based 3D printing was used to generate 
customized scaffolds with cell-instructive biomaterials. A method was devised using readily 
accessible or open-source software to design anatomically-shaped and porous scaffolds with 
discrete bone and cartilage regions as well as an interfacial region. Two types of 3D printing 
tools, fused deposition modeling (FDM) and direct ink writing (DIW), were used to deposit 
materials in a layer-by-layer fashion to translate the digital model into a scaffold using a 
customized desktop 3D printer. Monofilament feedstock for FDM was fabricated with 
polycaprolactone, a biodegradable polymer, and hydroxyapatite nanoparticles, which have been 
shown to enhance osteogenesis and were used to print the bone region.91 The chondroinductive 
region was made with hyaluronic acid-based hydrogel, a constituent of native cartilage, enriched 
with decellularized cartilage (DCC) microparticles, which have shown great promise in 
promoting cartilage growth. 
 
PATIENT DATA-DRIVEN SCAFFOLD PRODUCTION 
The general method for the computer-aided design and manufacture of patient-specific 
scaffolds for tissue engineering is depicted in Figure 4.1. First, medical data from computed 
tomography (CT) or magnetic resonance imaging (MRI) is required in order to acquire 
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information about the dimensions and shape of the area of interest. The scans are then merged to 
render a 3D volume so that a surface mesh of the desired subvolume can be created. Once 
generated, the mesh is repaired to remove non-manifold elements to ensure that it is watertight. 
Next, the mesh is converted into a solid base feature so that it can be modified with CAD 
modeling software to introduce an interconnected pore structure and design additional scaffold 
features. Once finalized, the model is exported as an STL file and translated into G-code, through 
the use of ‘slicing’ software, which slices the model into layers and defines the printer 
movements and tool path within each layer. To generate G-code that yields high-quality printed 
objects, printing parameters within the slicing software such as extrusion temperature and 
printing speed among others must be sufficiently defined for each material. After the G-code 
script is generated, the script is sent to the printer and the line-by-line commands are executed 
until the 3D scaffold is fully realized. In addition to selecting adequate printing parameters, the 
printing process is also highly dependent on the mechanical printer calibrations as well as the 
physical properties of the material feedstock. Once printed, the 3D-printed scaffold and the CAD 
model are compared, and if discrepancies are observed, printing parameter adjustments, 
biomaterial development, hardware modifications, printer calibrations, or model redesigns are 
performed. This process is highly iterative and the quality and resolution of the scaffold rely on 
the interdependency of technical, structural and material factors. Additionally, the software 
toolchain, which is the list and order of software programs used to translate 2D medical scans 
into 3D-printed scaffolds, is summarized in Figure 4.2. All of the software employed in this 
investigation was either free or open-source, and is listed beneath the software toolchain flow 
chart.  
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MATERIALS AND METHODS 
Scaffold Design 
CT Data Processing/Mesh Creation 
CT imaging was performed on a porcine head to acquire DICOM files, which capture and 
store the 2D scans (Figure 4.3A). 3D Slicer, an open-source medical image processing software, 
was used to convert the 2D medical scans into a 3D surface model of the mandibular condyle, 
which is a format suitable for import into CAD modeling software (Figure 4.3B). After the 
DICOM data were loaded, bone regions were isolated and rendered to visualize the 3D volume 
by defining the intensity threshold. The 3D rendering was then cropped to encompass the left 
mandibular condyle, and a label map based on intensity and location was created to differentiate 
the temporal region from the mandibular region of the TMJ in order to trim away superfluous 
tissue.92 Once each region was labeled and segmented, the mandibular region was selected and a 
surface model or mesh of that segment was generated and exported in an STL file format.  
 
Mesh Repair 
Once an STL file of the mandibular condyle was obtained from the CT data, the surface 
mesh was processed and fixed to repair surface holes, make the mesh manifold, remove floating 
surfaces, and reduce the number of faces to below 10,000 for successful upload into Autodesk 
Inventor, a CAD modeling software. A series of open-source software programs were used in 
combination to re-mesh the surface model to a satisfactory level. MeshLab was used to re-orient 
the mandibular condyle and remove holes and nonmanifold elements. Netfabb Basic was used to 
crop the mandibular condyle to produce cleaner geometries, and remove extraneous surfaces and 
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other noise. Lastly, Autodesk Meshmixer was used to reduce the number of faces and smooth the 
surface of the condyle to remove topographical errors (Figure 4.3C).  
 
CAD Modeling 
The fixed STL file was imported into Autodesk Inventor and the mesh data was 
converted to a solid base feature with the Mesh Enabler plugin (free for students). Pore channels 
were introduced to create struts 0.5 mm in width, which is the minimum allowable width for the 
0.5 mm extrusion nozzle, and 0.9 mm in height corresponding to three printed layers with 
heights of 0.3 mm. Since layer height must be less than 80 percent of the nozzle size (according 
to a heuristic), a layer height of 0.3 mm is considered acceptable. The pore channels were 600 
µm in width and 900 µm high, which lies within the ideal pore size range for osteoinductive 
scaffolds (greater than 300 µm for bone growth and vascularization and between 500-1000 µm to 
stimulate proliferation).93, 94 The pores were interconnected and placed in 0-90 degree 
orientations to increase cell seeding, enable homogenous cell distributions, and facilitate efficient 
nutrient transport.59, 88 
 Since the CT scan data does not resolve condylar cartilage, a cartilage region was 
designed through direct graphical manipulation of the mesh using Autodesk Meshmixer. The 
surface of the condyle was offset by 2 mm to mimic the height of native condylar cartilage, and 
the soft transition function was applied to establish continuity between the offset surface and 
underlying condylar body. To further enhance the design, the sculpt function was used to 
perform manual reshaping, and the smooth function was used to simplify the mesh representing 
the condylar surface. After edits were made, the model was exported as an STL file, imported 
into Autodesk Inventor, and converted to a solid base.  
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 To create the cartilage region, an independent bone region was created that, when 
subtracted from the sculpted model through Boolean operations, produced a cartilage region that 
was solid above the interface and that enmeshed with the bone region below the interface. The 
cartilage region was designed to extend into the top three strut layers of the bone region to 
anchor the hydrogel into the thermoplastic-based region and prevent delamination. In this region, 
the spacing between the struts of the bone region was enlarged to 0.9 mm to accommodate 
insertion of the dispensing tip for hydrogel deposition within the confines of the thermoplastic-
based struts. Once both regions were created they were exported as individual STL files for 
upload into Slic3r, a slicing software, for G-code generation. The finalized scaffold design is 
displayed in Figure 4.3D. 
 
Hardware Development 
An extrusion tool was built and attached to an existing RepRapPro Mendel Tricolor 3D 
Printer to enable the co-deposition of fluids and thermoplastic-based filaments for the creation of 
complex, multi-material structures. The open-source extrusion tool was constructed from 3D-
printed parts to enable motor-controlled linear actuation of 10-mL syringes. Through the 
displacement of the syringe plunger, fluidic materials were driven through tubing and an 18-
gauge dispensing tip, which was secured to the motorized print head to allow for the deposition 
of fluids in programmed patterns. The syringe-based extrusion tool in combination with a UV 
lamp attachment provided the means to print photocurable hydrogels in the present study. For 
further details on the syringe-based extrusion tool and 3D printer setup see Chapter 3. In 
addition, the 3D printer was equipped with two Bowden-style extruders, which were mounted to 
the frame of the 3D printer and drive filament through stiff tubing and into heated nozzles 
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located on the motorized print head. The customized 3D printer therefore has the capacity to 
print with two filaments and one fluidic material to construct multi-material 3D objects. Lastly, 
Kapton tape was applied to the surface of the print bed to facilitate first-layer adhesion, and is a 
common practice in FDM.  
 
Biomaterial Development 
Osteoinductive ‘Ink’ Development 
Monofilament Production 
Various thermoplastic-based monofilaments were produced for 3D printing with the 
FDM extrusion tool. The following thermoplastic monofilaments were attempted with a single-
screw extruder: 14 kDa-PCL, 80 kDa-PCL and PLA, 14 kDa-PCL + 5 wt% HAnp, 80 kDa-PCL 
+ 5 wt% HAnp, PLA + 5 wt% HAnp. Unless otherwise stated, all materials were purchased from 
Sigma-Aldrich.  To make PCL + 5 wt% HAnp monofilaments, PCL pellets and 5 wt% 
hydroxyapatite nanopowder were combined and melted in an oven at 75°C with occasional 
stirring to achieve a consistent mixture. Once cooled, the composite materials were manually 
granulated into pellets with approximate sizes of 3-5 mm. The pellets were then extruded 
through an annular die with a diameter of 1.65 mm using a single-screw extruder (Filabot 
Original Filament Extruder, Barre, VT) at a temperature of 95°C. Once extruded, a cooling fan 
was used to facilitate rapid solidification to ensure that the cross-section remained circular with a 
consistent diameter of 1.75 mm for input into the Bowden extrusion tool. For PLA + 5 wt% 
HAnp monofilament production, compounding was carried out at 220°C, and PLA-based pellets 
were extruded at 235°C through a 1.95 mm annular die to produce monofilaments roughly 1.75 
mm in diameter. 
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Monofilament Printing 
 Once pure polymeric and composite monofilaments were prepared, they were threaded 
into the Bowden extrusion tool and extruded at 100 mm/min. The nozzle temperature was set to 
220°C for PLA-based filaments and 110°C for PCL-based filaments. However, none of the 
filaments produced with the single-screw extruder were tolerated by the 3D printer. Every 
filament caused the extrusion tool to jam, and the tool had to be dismantled and rebuilt after each 
blockage. To address this limitation, alternative 3D printing methods for patient-specific scaffold 
production with thermoplastic/HAnp composites, such as indirect 3D printing and solvent 
printing, were investigated. 
 
Indirect 3D Printing 
  Indirect 3D printing methods were employed to construct a shape-specific bone region 
with CAD-generated pore architecture using PCL and 5 wt% HAnp. First, a negative or inverse 
3D model of a cylinder with interconnected microchannels was designed where the voids in the 
sketch corresponded to the overall structure of the scaffold. Next, the negative mold was printed 
at 228°C with a printing speed of 15 mm/s using polystyrene filament (MatterHackers, Orange 
County, CA). PCL powder with 5 wt% HAnp was loaded into the mold and raised to 80°C to 
melt the PCL. Once melted, more material was packed and tamped down into the mold to ensure 
uniform loading and an even distribution of material throughout. The sacrificial mold containing 
the hardened PCL and HAnp cast was selectively removed through dissolution in Citra Solv, 
leaving the insoluble PCL/HAnp structure.  
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Solvent Printing 
To test the feasibility of printing PCL/HAnp structures with the syringe-based extrusion 
tool, PCL dissolved in dichloromethane (DCM) containing HAnp suspensions was loaded into a 
syringe and extruded. First, 0.33 g of HAnp were added to 8.25 mL of dichloromethane (DCM) 
and sonicated until a stable suspension was achieved. In parallel, 3 g of PCL was dissolved in 
100 mL of DCM, and then mixed with the HAnp suspension. The mixture was then loaded into 
Luer-Lok syringes to test syringe-based extrusion through 20- and 18-gauge dispensing tips. 
After extrusion onto a surface, the solvent was allowed to evaporate to yield a stable PCL/HAnp 
deposit, and the remaining extrudate was qualitatively assessed. 
 
Chondroinductive ‘Ink’ Preparation 
In Chapter 3, hydrogels comprised of PHA and DCC microparticles were optimized to 
construct multilayered 3D hydrogels with the current 3D printer system. Based on findings, 3 
w/v% 1 MDa-PHA hydrogel precursor solution with suspensions of 15 w/v% DCC 
microparticles was arguably superior to other tested chondroinductive ‘ink’ formulations as it 
yielded the highest-resolution 3D hydrogel structures. Moreover, the crosslinked hydrogels were 
shown to support cell growth, and possessed chondroinductive potential. Previously described 
protocols were used to synthesize PHA and DCC microparticles. In brief, PHA was synthesized 
by reacting hyaluronic acid with a 5-fold molar excess of pentenoic anhydride in a 3:2 v/v ratio 
of water to DMF maintained at a pH of 8 to 9 under continuous stirring to yield degrees of 
functionalization ranging from 22-28% as verified through HNMR spectroscopy. DCC 
microparticles were prepared by first harvesting articular cartilage from porcine knees. Once 
harvested, cells and immunogenic epitopes were removed through a multistep process involving 
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tissue fragmentation, enzymatic breakdown, osmotic shock, and detergent and solvent washes. 
Through double-stranded DNA quantification, 76% of the cells were removed. The resulting 
decellularized matrix was further processed with a cryogenic mill to pulverize the DCC to 
micron-sized particles. To prepare the chondroinductive ink, 150 mg of PHA, 58.44 mg of 
dithiothreitol (DTT), and 750 mg of DCC were mixed with 5 mL of PBS containing 2.5 mg of 
dissolved Irgacure 2959. The mixture was then centrifuged to remove air bubbles and was loaded 
into a 10 mL Luer-Lok syringe for printing with the syringe-based extrusion tool. 
 
Scaffold Manufacture 
The individual mesh designs of the respective bone and cartilage regions were uploaded 
in STL file formats into Slic3r, an open-source slicing software, where the meshes were 
converted into line-by-line printer instructions in the form of G-code based on complex 
algorithms and user-defined print settings. Subsequently, the G-code script was modified to 
achieve acceptable 3D-printed objects with the syringe-based extrusion tool as described in 
Chapter 3. The G-code was then forwarded to the Marlin firmware, which is located on the 
printer controller board, through the host interface software, Pronterface. All software programs 
used in scaffold prototyping were either free to students or open-source downloads from the 
Internet. Once the print job was initiated and the G-code commands were executed to produce a 
3D-printed object, the overall build quality and dimensional accuracy of the object was 
evaluated. Based on these output evaluations, parameters were adjusted in Slic3r to enhance the 
overall quality of the product. Printing parameters are dependent on the hardware, software and 
printing material, and substantial deviations in printing parameters are expected when the 3D 
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printing technique, print design or feedstock material is changed. Therefore, care must be taken 
to select suitable parameters through iteration for the construction of novel 3D designs. 
To produce the bone region of the scaffold, FDM was used to print commercial 
monofilament (PCL or PLA) to validate model production by 3D printing. Each thermoplastic 
filament was loaded into the Bowden extrusion tool and printed at various temperatures and 
defined printing parameters to achieve suitable build dimensions and features. PCL and PLA 
from MakerBot were used to print the bone region of the scaffold to validate the model. 
Composite and commercial PCL filaments were not suitable for printing, and will be discussed 
in further detail in subsequent sections. PLA was therefore used to print the bone region during 
biphasic scaffold production to demonstrate proof-of-concept. The cartilage compartment was 
printed with 3 w/v% PHA and 15 w/v% DCC hydrogel ink with the syringe-based extrusion tool 
and the bone compartment was printed with the Bowden-style extruder. The model design was 
cropped to contain only the top three strut layers of the bone region and the cartilage overlay to 
evaluate the co-deposition of materials with the 3D printing system and to qualitatively assess 
the integration of the two dissimilar materials in the interfacial region of the scaffold.  
 
RESULTS 
Custom-Made Filament Evaluation 
Filaments were produced with a Filabot Original Filament Extruder by adjusting the 
extrusion temperature and annular die diameter to yield an approximate filament diameter of 
1.75 mm. In addition, a cooling fan was aimed at the outlet nozzle to accelerate material 
solidification once extruded to improve shape fidelity and dimensional accuracy. Once steady-
state extrusion was attained, the filament was collected in coils at ground level and the width was 
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measured at different locations along the length of the filament to evaluate cross-sectional 
uniformity. Visual or qualitative assessments were also performed to inspect for inconsistencies 
in appearance.  
Filament production using 15 kDa-PCL flakes and 15 kDa-PCL + 5% HAnp pellets was 
attempted, but the materials did not extrude as continuous filaments. Rather, the material was 
extruded out in small grainy masses. 80 kDa-PCL filaments when extruded tended to puff out at 
the outlet of the die, but dramatically thinned to the point of breakage as the filament was driven 
outward since rapid hardening did not occur despite the presence of a cooling fan. Even at the 
lowest extrudable temperature of 65°C, the extrudate had a melted appearance and poor shape 
retention. Extrusion was even carried out in refrigerated conditions to help secure the shape of 
the filament once extruded, but the cooling fan alone proved to be equally as effective. To 
diminish filament thinning and subsequent breakage, a basin of deionized water was placed just 
under the extruder outlet to facilitate rapid cooling and solidification of the filament. This 
method was effective at stabilizing the extruded filament, but with this setup the filament had to 
be manually collected, which introduced slight defects in the filament upstream of the 
perturbations, and steady state conditions were unattainable. With this method, a die size of 1.65 
mm was selected to produce PCL-based filaments with widths of ~1.75 mm. In contrast, PLA-
based filaments cooled rapidly once extruded, which obviated the need for immediate entry into 
a cooling bath. The cooling fan alone was enough to stabilize the extruded PLA-based filament. 
The extrusion temperatures for PLA and PLA + 5% HAnp were 205 and 215°C, respectively; 
however, the material once extruded took on a discolored or burned appearance. 
 Extrudability tests with filament removed from the region of steady state production was 
loaded into the Bowden extrusion tool and was extruded at 100 mm/min to determine whether 
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filaments made in-house could be tolerated by the 3D printing system. However, none of the 
filaments were able to achieve consistent extrusion. Where the filament was too thin, the idler 
and toothed gear did not provide enough tension to drive the filament through the Bowden tubing 
and heated extrusion nozzle. Where the filament was too thick, it either jammed the idler, 
causing the stepper motor to jam, or blocked the tubing or extrusion nozzle. With filament jams 
and blockages, the extrusion tool had to be dismantled and rebuilt. Also, the tool could not 
handle bends in the filament or any inconsistencies that deviated from 1.75 mm within a slim 
margin as they would also jam the tool. The allowed variation for many FDM filaments is 1.75 ± 
0.05 mm, though no number could be verified for the current 3D printer. Variations in filament 
diameter not only limit extrusion, but also if printable, introduce variation into the printed part in 
terms of size and strength.95 To improve the filament making process, speed control, real-time 
measurements of the filament diameter with a laser micrometer, and a steady state filament 
collection or coiling method would go a long way in minimizing the variation to within the 
acceptable tolerance. 
 For composite filaments, the added complication of manual compounding and 
granulating was undesirable, as it was difficult to manually incorporate HAnp into the melted 
thermoplastics. PCL with 10% HAnp was attempted, but the powder could not be pounded into 
the material at that concentration by hand as the molten thermoplastic was too viscous. 
Therefore, 5% HAnp was used for proof-of-concept.  
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Bone Region Construction 
Direct 3D Printing 
The bone region of the scaffold was printed with thermoplastic-based filaments to 
confirm that the model could be translated into an equivalent 3D structure with an FDM 
extrusion tool and to determine valid print and material settings for biphasic scaffold production. 
38 layers were printed in total with heights of 0.3 mm and alternating 0-90° rectilinear infill 
patterns that together formed a crosshatched internal architecture with an external shape of the 
porcine mandibular condyle head and neck. Since the 3D printing system could not tolerate the 
dimensional inconsistencies of filaments made in-house, commercial PCL and PLA filaments 
were used to prove feasibility. Printing parameters were adjusted in the slicing software to 
achieve accurate, high-quality scaffold features. For PCL filament, considerable parametric 
optimization was performed changing critical parameters such as printing speed, extrusion 
volume, extruder temperature, build plate temperature, interlayer cooling times, infill pattern, 
infill density and various retraction factors, but scaffolds could not be produced. Print tests with 
dissolvable support structures were also attempted to improve the deposition of PCL in 
crosshatched layers, but porous structures could not be manufactured. The eventual failure of all 
test prints was due to ghosting, where extruded material was not deposited onto the previous 
layer. This ghosting phenomenon was thought to be due to inconsistent extrusion with the FDM 
extrusion tool. Though PCL exhibited good layer adherence when deposited on solid surfaces, 
PCL was not able to form crosshatched or porous structures. The material would not form 
bridges over void spaces, but rather the material preferentially adhered to the nozzle head 
forming misshapen globules that were irregularly deposited onto the printed object. Since other 
groups have successfully manufactured porous PCL scaffolds with void spaces and even more 
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intricate porous designs using 3D printing technologies, these production challenges were 
thought to be due to the method of printing itself.70, 96 Since PCL is flexible, there are significant 
difficulties in printing intricate structures with a Bowden-style extruder, which does not have 
sufficient pressure to push flexible filament through the hot end. When driven through the 
tubing, the filament flexes rather than forces itself through the hot end, thereby causing 
deviations in extrusion volume, which introduces errors into the 3D-printed structure. 3D 
printing forums have corroborated this phenomenon, and Bowden-style extrusion is therefore not 
recommended for use with flexible filaments. Other extrusion techniques such as direct or 
pneumatic extrusion as well as other 3D printing techniques such as selective laser sintering have 
been used to successfully manufacture PCL scaffolds with porous internal architectures, and 
could instead be employed.  
In addition to ghosting, substantial stringiness and areas of warping were observed in 
PCL prints. Since the melting temperature of PCL is low (~65°C), PCL does not immediately 
harden upon extrusion like PLA or ABS thermoplastics, which have high melting temperatures 
(~200 and 230°C, respectively). PCL is instead viscous after deposition and the structural 
instability of melted PCL leads to flattening, thereby distorting the overall print. Therefore, it 
was determined that a cool down time of at least 90 seconds should be implemented in between 
layers to enable solidification to prevent warping and to support the next print layer.  
PLA, a widely available and commonly used thermoplastic for conventional FDM 
techniques, was used to print the bone region design.97 The scaffold was printed at an extrusion 
temperature of 215°C, and a print speed of 15 mm/s. The resulting 3D-printed structure closely 
matched the model and programmed deposition path and was nearly identical to the model in 
shape, dimension and pore size (Figure 4.4).  
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Even though HAnp was not incorporated in the prototype, there is evidence to suggest 
that 3D-printed scaffolds constructed of pure commercial PLA filament alone can promote 
osteogenesis through the incorporation of biomimetic microstructures.90 Preliminary data suggest 
that PLA microstructures that mimic the architectural properties of bone, such as concentric 
circles, in the absence of other bioactive factors can support cellular adhesion and promote 
osteogenesis through purely structural cues.90 Employing biomimetic structural features may 
therefore be one approach in overcoming the need for composite filament. However, two other 
methods were investigated as workarounds to construct well-defined PCL/HAnp scaffolds while 
avoiding the need for composite monofilaments. 
 
Indirect 3D Printing 
To overcome technical and material constraints of patient-specific scaffold production 
with PCL and hydroxyapatite additives using FDM, indirect rapid prototyping was investigated. 
Sacrificial molds were designed with CAD software and printed with polystyrene filament 
followed by traditional melt casting of osteoinductive composite material to establish a shape-
specific external structure and user-designed interconnected pore channels. The indirect 3D 
printing process is shown in Figure 4.5, in which an inverse model was designed, printed and 
dissolved to yield a cylindrical scaffold with interconnected pores comprised of PCL and HAnp. 
The scaffold was successfully created to exact specifications and is a promising approach for 
single tissue engineering since well-defined scaffolds can be fabricated using materials that are 
otherwise unacceptable for direct 3D printing. This approach employs 3D printing to create 
molds with highly printable, commercially available filament that yield high-resolution casts of 
novel biomaterials, which may be otherwise difficult to attain through direct 3D printing. Since 
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indirect 3D printing enables the production of scaffolds with composite biomaterials to precise 
specifications, the need for novel filament fabrication is obviated. This approach is promising 
and several researchers have employed indirect 3D printing for osteochondral tissue 
engineering.98 However, these studies typically manufacture the bone and cartilage regions 
separately and use fibrin glue or sutures to adhere the two regions, which oftentimes leads to a 
structurally weakened interface and subsequent delamination.90 Direct 3D printing in contrast 
enables the sequential deposition of materials so that two materials can be deposited in 
customized patterns within the same layer to better integrate the materials and reinforce the 
interface to ensure long-term success and resistance against deformation. Although a viable 
option, direct 3D printing has apparent advantages over an indirect approach in generating well-
integrated osteochondral scaffolds for biological joint regeneration. 
 
Solvent Printing 
The feasibility of direct 3D printing with stable HAnp suspensions in PCL solution was 
examined by extruding PCL/HAnp in DCM through a 10-mL Luer lock syringe equipped with 
an 18-gauge dispensing tip onto paper. The solution deposited smoothly onto the paper and the 
solvent appeared to evaporate within 5 minutes leaving patterned residues of PCL and HAnp. 
Manual syringe extrusion before and after solvent evaporation is shown in Figure 4.6. From 
macroscopic observation, the extrudates shrunk along all axes after solvent evaporation and 
exhibited moderate changes in shape and dimension. While PCL and HAnp in solvent can be 
extruded as continuous filaments by a syringe, devising a process to produce scaffolds with this 
mixture using the syringe-based extrusion tool may be challenging. Advanced design strategies 
and customized G-code would be required to account for evaporation and the accompanied 
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changes in shape and dimension of the deposited material. While solvent printing offers 
flexibility and versatility by allowing for direct 3D printing of novel composite materials, 
methodologies would have to be extensively developed in order to create reproducible prints.  
 
Biphasic Scaffold Design and Manufacture 
The biphasic scaffold design was cropped to evaluate the feasibility of constructing a 
multilayered scaffold in the anatomical shape of a porcine condylar head with well-integrated 
bone and cartilage regions by co-depositing PLA filament and 3% PHA + 15% DCC hydrogel 
ink with the customized 3D printer. The complex scaffold consisted of a bone region with 600 – 
900 µm pore channels to facilitate transport of nutrients and waste and a cartilage region, which 
resided on the superior surface of the condylar head and was designed to match dimensions 
found in literature. To integrate the two regions, chondroinductive ink was deposited in between 
the PLA struts for 3 strut layers to anchor the hydrogel into the thermoplastic lattice to prevent 
delamination. Before printing the model, the two extrusion tools employed in the printing job 
(syringe-based and FDM extruders) were carefully offset and defined in Slic3r to enable dual-
printing and to equilibrate the coordinates. Printing this scaffold however proved challenging. 
The hydrogel did not deposit smoothly in between the struts of the bone region, causing broad 
dispersal of hydrogel across the surface. In addition, the hydrogel was destroyed during printing 
due to the high processing temperatures of PLA. When printing upon layers containing hydrogel, 
the hot end extruder nozzle caused the hydrogel in close proximity to singe and brown. Due to 
these occurrences, the prints were messy and were not successfully executed. Furthermore, tool 
switching caused a lot of odd behaviors that were not implicit in the G-code script. Most notably, 
communication between the host interface software and the controller board was often lost when 
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tool changes were made. Consequently, printer movements would stop indefinitely and the print 




The production of patient data-driven scaffolds with osteo- and chondroinductive 
biomaterials with CAD/CAM technologies relies on the interdependence of hardware and 
software capabilities, the complexity and translatability of the scaffold design, and the ease in 
which the biomaterials can be processed. Therefore, hurdles in any one of these areas can 
negatively affect or compromise the feasibility of scaffold production entirely. This work marks 
the beginning of developing an approach to print with both thermoplastic-based filament and 
hydrogel to construct a multilayered scaffold with separate bone and cartilage compartments and 
an integrated interface to promote mandibular condyle regeneration. However, many limitations 
need to be overcome to further advance this therapy.  
First, since the implementation of 3D printing for tissue engineering applications is still 
emerging, there is a shortage of biomaterials available for 3D printing. Therefore, printable 
biomaterials must be newly engineered or established biomaterials must be adapted for 3D 
printing, specific to the printing technique employed. The current study aimed to adapt an 
established osteoinductive biomaterial, PCL with apatite additives, for printing with an open-
source desktop 3D printer using a Bowden extrusion tool. This was accomplished by the 
fabrication of composite filament. However, the 3D printer could not tolerate the slight cross-
sectional inconsistencies of composite filaments produced in-house. Aside from attempting to 
improve the diametric consistency by altering the extrusion temperature, molecular weight of the 
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polymer, method of collection, and cooling arrangement, indirect 3D printing and direct 3D 
printing of PCL and HAnp in solution were considered in order to bypass filament production 
altogether. While both approaches seemed to enable scaffold production with PCL and HAnp, 
both methods have their individual advantages and disadvantages. Indirect 3D printing is highly 
advantageous in that it can facilitate the production of CAD-designed scaffolds with biomaterials 
that are otherwise unprintable. In this process, melted biomaterial is cast into a 3D-printed 
sacrificial mold and the final scaffold is retrieved by selective dissolution of the mold. While this 
method provides a certain level of control over the external geometry and internal pore structure 
of the scaffold, it prevents the patterning of multiple materials within the same plane of the 
scaffold, which is not ideal for multi-tissue or interfacial tissue engineering applications. In 
contrast, solvent printing enables multiple materials to be deposited within single layers of the 
scaffold in a controlled manner. However, solvent evaporation changes the structure and 
dimensions of the depositions. While this method also circumvents the need for novel, composite 
filaments, advanced methodologies would need to be developed to account for solvent 
evaporation and associated shrinkages of the print in order to produce a scaffold that correlates to 
the CAD model. 
 Another limitation that impeded scaffold production lied in the mechanics of the filament 
extrusion tool. The Bowden-style extrusion tool was unable to drive consistent volumes of PCL 
through the heated nozzle, which translated into large discrepancies in the printed structure, 
leading to either immediate or eventual print failure. For Bowden-style extrusion, filament must 
be pushed through both tubing and a heated nozzle by a remote stepper motor. However, due to 
the innate flexibility of PCL, the filament tended to buckle within the tubing rather than progress 
through the nozzle, causing inconsistent extrusion. To overcome this hurdle, a 3D-printer 
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equipped with a direct extruder or a temperature-controlled pneumatic or syringe-based extruder 
could be used. Theoretically, the Bowden set-up could also be rebuilt with highly restrictive parts 
to prevent the PCL filament from flexing.   
Furthermore, extensive optimization needs to be performed to construct regions 
containing both hydrogel and thermoplastic-based materials within the same layer. During multi-
material prints, deposited hydrogels were scorched beyond repair due to run-ins with the heated 
nozzle of the filament extruder. One way to avoid hydrogel scorching would be to improve the 
positioning accuracy of the print head to achieve more precise movements and prevent contact 
between the heated nozzle and printed hydrogel. Moreover, the resolution and overall extrusion 
quality of the hydrogel ink was unacceptable. When the hydrogel ink was dispensed in between 
the thermoplastic struts of the bone region, the hydrogel neither formed continuous strands nor 
remained within the struts. The messiness of the hydrogel depositions in large part is thought to 
be due to the rudimentary nature of the custom-built syringe-based extruder. The extruder can 
not produce high-resolution filament strands and also experiences significant material leakage 
out of the dispensing tip during prints. This leakage not only causes issues in maintaining 
consistent extrusion volumes, but also leads to random droplets of material falling onto the 
printed object. An extrusion tool, either pneumatically or piston-driven, with a valve to prevent 
unwanted flow of material would therefore be highly desirable.  
Lastly, due to the open-source nature of these 3D printing technologies, consistent 
technical glitches and reliability issues were encountered.  
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CONCLUSIONS 
Scaffold prototyping is a highly iterative process that relies on the interdependency of its 
four main stages: design, manufacture, biomaterial development and hardware development. The 
above study endeavored to design porous, osteochondral scaffolds based on patient data with 
cartilage and bone regions and an integrated interfacial region for manufacture with DIW and 
FDM techniques. Osteoinductive feedstock development for FDM was also explored; though 
composite filaments were unusable as they contained cross-sectional inconsistencies that were 
not tolerated by the extrusion tool. For proof-of-concept, the osteochondral scaffold design was 
printed with 3% PHA + 15% DCC hydrogel ink for the cartilage region and PLA thermoplastic 
for the bone region. However, due to intrinsic limitations in material processing and the 
mechanics of the extrusion tool, further advancements are required to feasibly produce the 
patient-specific osteochondral scaffolds.  
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Chapter 5: Conclusions and Future Directions 
This thesis marks the early development of patient-specific osteochondral scaffolds 
composed of hydrogel and thermoplastic-based materials using combined 3D printing 
techniques. First, chondroinductive hydrogel ‘ink’ was developed as the material feedstock for 
syringe-based extrusion. Pentenoate-modified hyaluronic acid (PHA) pre-gel enhanced with 
decellularized cartilage (DCC) microparticles, showed favorable rheological properties for 3D 
printing, having observable yield stresses, shear-thinning behavior and high yet tolerable 
viscosities. In a concentration-dependent manner, DCC microparticles enhanced the structure of 
PHA pre-gel and crosslinked PHA hydrogel networks due to increased interparticle forces, 
which improved both the resolution, and mechanical stiffness and strength of the 3D-printed 
structures. Furthermore, the compressive mechanical properties of 3D-printed and mold-casted 
hydrogels were not statistically different, revealing that the layer-by-layer patterning of 
hydrogels does not reduce the mechanical integrity of the overall structure. Lastly, hydrogels 
with higher concentrations of DCC were shown to stimulate larger fold-increases of certain 
chondrogenic gene markers in vitro, signifying chondroinductive potential.  
To further characterize PHA/DCC hydrogel for potential use in acellular joint 
regeneration therapies, cell infiltration should be studied in 3D-printed gels to investigate 
whether endogenous progenitor cells from the bone marrow can penetrate and remodel the 
hydrogel network. In addition, implantation into an animal model would be useful to evaluate the 
efficacy of 3D-printed PHA/DCC hydrogels to regenerate cartilage in vivo. To further enhance 
the hydrogel to function as a cartilage substitute prior to tissue ingrowth, the mechanical 
properties must be increased to have similar magnitudes to those of native cartilage so that the 
hydrogel can withstand physiologically relevant loads. To improve the mechanical properties, 
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the crosslinking density can be increased or structural thermoplastic lattice structures could be 
co-deposited within the hydrogel scaffold to improve mechanical robustness. 
The discrete bone region of the scaffold should also be optimized and characterized. 
First, a method must be to devised to produce consistent filaments with inherent osteoinductive 
potential for FDM. Additionally, pore shape, size and organization should be investigated to 
produce scaffolds that through mechanotransduction elicit osteogenesis and bony ingrowth. 
More complex microarchitectures, which mimic the structural features of bone, should also be 
considered. 
Lastly, open-source software platforms were used to convert medical informatics into 
digital models representing the anatomical shape of the mandibular condyle, which were 
successfully modified with CAD techniques to yield patient-specific scaffolds. However, 
significant constraints were imposed in the manufacture of this design. The following 
improvements must therefore be employed in order to further advance this technology: 
•   Higher resolution hydrogel printing tool with valve to prevent drips 
•   Method to produce consistent 1.75 mm composite filament to enable PCL/HAnp printing 
•   3D printer that can support direct rather than Bowden-style filament extrusion for flexible 
filament printing 
•   Commercially developed software and hardware tooling to bypass technical glitches and 
reliability issues 
•   Advanced G-code algorithms or development of extensive manual scripts to optimize 
printer instructions and tool paths for scaffold production with novel biomaterials  
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Figure 3.1. A) Schematic of pentenoate functionalization of hyaluronic acid. B) Hydrogel 
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Figure 3.3. Confirmation of pentenoate functionalization of HA. HNMR spectra for pentenoate-
modified hyaluronic acid (PHA) compared to pure hyaluronic acid (HA). Peaks at 2.25, 2.5, 5.0 
and 5.75 are indicative of pentenoate functionalization. The degree of functionalization was 
determined by comparing the intensities of the peaks located at 1.75 and 5.75 ppm (i.e., the 
relative amount of H2’’ protons to the amount of HC protons). 
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Figure 3.4. Confirmation of cartilage decellularization. Fluorometric dsDNA quantification of 
cryoground native porcine cartilage and decellularized cartilage (DCC). Results are reported as 
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Figure 3.5. Printability tests of PHA hydrogel inks with varied concentrations (2, 3 and 4 w/v%) 
and molecular weights of PHA (100, 500, 700 and 1000 kDa). A) Image of the extrusion of 3 
w/v% 1MDa-PHA hydrogel ink as a stable filament strand from an 18-gauge dispensing tip. B) 
Summary of the printability of various PHA hydrogel ink formulations. C) Depiction of single-
layer 1 cm x 1 cm test print and representative images of various PHA hydrogel ink depositions 
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Figure 3.6. Scheme for printing hydrogel layers, and images of 3D-printed PHA/DCC 
hydrogels. A) Depiction of 3D-printed 16-layer hydrogel assembly. The CAD model (green) is 
converted into user-generated tool paths (red) with slicing software. Hydrogel ink is deposited 
with 0-90° rectilinear infill patterns. After every 2 layers, the printed structure is cured with UV 
light for 90 seconds until the final structure is realized. B) Macroscopic images of 16-layered, 
3D-printed PHA hydrogels with 0, 5, 10 and 15 w/v% DCC microparticles constructed with the 
syringe-based extrusion tool. The base of the hydrogels are 1 cm x 1 cm. 
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Figure 3.7. Rheological properties of various hydrogel formulations. A) Representative flow 
curves of PHA/DCC precursor mixtures. B) Yield stress and C) Storage and loss moduli reported 
as mean ± standard deviation in Pascals for PHA hydrogel precursor mixtures containing 0, 5, 10 
and 15% DCC particles. * denotes statistically significant differences from 0% DCC group, @ 
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Figure 3.8. Effect of DCC enrichment and fabrication method on mechanical properties of PHA 
hydrogel. A) Compressive stiffness and B) Compressive strength reported as mean ± standard 
deviation in units of kPa for PHA hydrogels containing 0, 5, 10 and 15% DCC microparticles 
fabricated by mold-casting (gray) and 3D-printing (green) methods. No significant differences 
were found between mold-casted and 3D-printed gels with the same hydrogel formulation. * 
denotes statistically significant difference from 0% DCC group with same fabrication method, @ 
denotes difference from 5% DCC group with same fabrication method, # denotes difference from 
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Figure 3.9. Mass-swelling ratio of PHA hydrogel with 0, 5, 10 and 15 w/v% DCC microparticles 
reported as mean ± standard deviation. * denotes statistically significant difference from 0% 






























   
 





Figure 3.10. Cytocompatibility of the developed hydrogel. A) LIVE/DEAD cell imaging (scale 
bars are equal to 200 µm) and B) Relative proliferation of rat bone marrow stem cells seeded on 
PHA hydrogels containing various concentrations of DCC microparticles over 10 days in 2D 
culture. * denotes statistically significant difference from 0% DCC formulation at same time 
point, @ denotes difference from 5% DCC at same time point, # denotes difference from 10% 
DCC at same time point, $ denotes difference from same formulation group at day 1, and & 
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Figure 3.11. Relative expression levels of chondrogenic genes encoding for A) Sox9, B) 
Aggrecan, C) Collagen II, and of D) Collagen I, an osteogenic gene. * denotes statistically 
significant difference from negative control group (0% DCC formulation) at same time point, @ 
denotes difference from 5% DCC at same time point, # denotes difference from 10% DCC at 
same time point, $ denotes difference from 15% DCC at same time point, & denotes difference 
from same formulation group at day 1, and + denotes difference from same formulation group at 
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Figure 3.12. Hematoxylin and Eosin staining from day 1 to week 4 of PHA/DCC hydrogel 
formulations seeded with cells. The nuclei are stained dark purple and cellular cytoplasm is 
stained pink. The scale bars are equal to 100 µm. 
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Figure 3.13. Safranin O and Fast Green stains of cells cultured on PHA hydrogels with various 
concentrations of DCC (5, 10 and 15%) compared to the negative (0% DCC) and positive control 
(0% DCC plus exogenous TGF-ß3 supplementation) over a four week period. Safranin O stains 
GAGs orange-red, and Fast Green stains noncollagenous materials green. The scale bars are 
equal to 100 µm. 
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Figure 3.14. DAPI and phalloidin fluorescent staining of cells cultured on PHA/DCC hydrogel 
formulations from day 1 to week 4. Cellular F-actin is depicted in green and the nuclei are 
depicted in blue. The scale bars are equal to 100 µm.  
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Figure 4.3. Computer-aided scaffold design process of the patient-specific osteochondral 
scaffold for mandibular condyle regeneration from CT scans of a hog head to a digital model of 
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Figure 4.4. Bone-promoting scaffold region of the condylar process.   
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Figure 4.6. Solvent printing of PCL and 10 w/w% HAnp dissolved/suspended in DCM before 
and after solvent evaporation. 
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